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ABSTRACT 
Protein hydrolysates are considered as a potential dietary source of natural 
antioxidants with important antihyperglycemic activity. This study was conducted to 
understand the effect of conventional and low-glycinin soy cultivars on the protein 
profiles and antioxidant capacity (AC) of their alcalase hydrolysates. The cultivars were 
grown in three different locations to identify which cultivar(s) exhibited the highest AC 
across multiple growing regions after alcalase hydrolysis. The peroxyl radical scavenging 
AC of soy peptides were also compared against purified β-conglycinin and glycinin 
hydrolysates. Another part of the study was conducted to understand the effect of in vitro 
simulated digestion of protein-based beverages and ingredients on the production of 
peptides with potent AC as well as α-glucosidase and α-amylase inhibitory activities. 
Nine protein-based beverages and ten functional ingredients (I-5 to 14) were analyzed for 
their AC and starch-hydrolyzing enzymes inhibitory activity. Four beverages and four 
protein-based ingredients were selected for in vitro digestion using pepsin and pancreatin. 
Statistical differences were observed in the protein profiles and AC among the 
different cultivars tested (p<0.05). Cultivars 1 and 6 had lower β-conglycinin subunits in 
comparison to the other cultivars. The hydrolysates from cultivar 3 grown in 
Bloomington, IL exhibited the highest AC against peroxyl radicals, compared to the other 
cultivars. Growing location appeared to have no effect on the soybean protein profiles 
and AC of soy protein hydrolysates. On average, AC for low glycinin soybean, high 
glycinin soybean and purified BC hydrolysates were not significantly different (p>0.05). 
Purified GL hydrolysate had an AC of 28.5 µM TE/µg soluble protein which was 
significantly different than low glycinin soybean hydrolysates (p<0.05).  
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All beverages showed no inhibition of α-amylase activity and only commercial 1, 
regular soymilk and low-glycinin soymilk beverages inhibited α-glucosidase by 9.8, 9.4 
and 10.2%, respectively. Non-protein based ingredients 8 and 14 exhibited α-glucosidase 
inhibitory activity with IC50 of 16.7 and 88.5 µg/mL, respectively and α-amylase 
inhibitory activity with IC50 of >2,500.0 and 325.1 µg/mL, respectively. After pepsin-
pancreatin hydrolysis, the AC and α-glucosidase inhibitory activity of protein-based 
beverages and ingredients increased significantly (p<0.05). Upon hydrolysis, SAI 3 
hydrolysate (SAI 3H) and SAI 4 hydrolysate (SAI 4H) had higher α-glucosidase 
inhibitory activity with 84.5 and 85.5%, respectively, than 1.0 mM acarbose with 62.8% 
inhibition. SAI 3H and 4H had similar peptide mass profile and were composed of unique 
peptides with masses 649.19, 884.55, 1108.60, 1139.73, 1152.43 and 1267.91 m/z.  
The study demonstrated the effect of cultivar, but not of growing location, on the soy 
protein subunit composition and AC of alcalase hydrolysates. The study also suggested 
the possibility to modify the protein profiles of soybean through breeding programs to 
produce soy hydrolysates with high AC, which could be further utilized as functional 
food ingredients. Another part of the study highlighted the importance of in vitro 
simulated digestion of protein-based beverages and ingredients on the production of 
peptides with potent antioxidant as well as α-glucosidase and α-amylase inhibitory 
activities. Overall, this research emphasized the importance of enzymatic hydrolysis to 
improve the antioxidant and antihyperglycemic potential of protein-based products.  
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CHAPTER 1 
INTRODUCTION 
 
Soy has been part of the human diet for centuries but not until recently has its 
popularity begun to explode in the United States. This was partly triggered by US Food 
and Drug Administration approval of the health claim that consumption of soy protein as 
part of a daily diet low in saturated fat and cholesterol helps fight coronary heart disease 
(FDA, 1999). Soybeans are commonly grown in Midwestern United States such as Iowa, 
Illinois, Indiana and Ohio. Cultivation is most appropriate in regions with hot summers 
since temperatures below 68°F can lead to significant growth retardation. Soy cultivars 
and growing locations play important roles in the production of compounds with high 
nutraceutical values such as isoflavone and bioactive peptides. Riedl et al. (2007) studied 
the influence of cultivar and growing location on soy isoflavone profiles and phenolic 
content. Wang et al. (2008) reported the influence of cultivar, environment conditions 
and processing on the concentration of lunasin in soybeans. Pesic et al. (2007) found 
significant differences in the levels of Kunitz (KTI) and Bowman-Birk (BBI) trypsin 
inhibitors among different soybean genotypes. 
Using plant breeding technology, growers can now develop a new line of soybean 
cultivars with high levels of β-conglycinin. These new cultivars are grown to cater 
consumer needs for better soy protein functionality (Bringe, 2006). β-conglycinin is  a 
soluble glycoprotein with no binding affinity to flavors, hence elevating its levels in 
soybeans improves soy binding capacity without affecting taste profile. In addition, β-
conglycinin is a good source of antioxidative peptides after enzymatic digestion. Chen et 
al. (1995) isolated six antioxidative peptides from proteolytic digest of β-conglycinin 
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using Protease S. Beermann et al. (2009) also characterized antioxidative peptides 
derived from pancreatic trypsin/chymotrypsin hydrolysis of soy β-conglycinin.  
With the current trend of merging nutraceutical with mainstream foods, soy products 
will take the center stage as consumer foods. In the US, common soy products that are 
available in the market are tofu, roasted soy nuts, soy yogurts and soymilk. Traditionally 
in Asia, soybean is fermented to produce soy sauce, miso, natto and tempeh. Recent 
research has shown that increased consumption of fermented soy products will delay or 
prevent the progression of type 2 diabetes mellitus (DM) (Kwon et al., 2010). This 
research is imperative since type 2 DM is a chronic disease whose impact is increasing 
rapidly worldwide (Pasupuleti and Anderson, 2008).  
One of the major determinants to the development of type 2 DM is postprandial 
hyperglycemia. According to Ceriello et al., 2005, postprandial hyperglycemia refers to 
the abnormal blood glucose level after a meal, usually caused by insulin resistance or 
combined with insulin deficiency. It is therefore essential to understand that the majority 
of blood glucose comes from the hydrolysis of dietary carbohydrates by pancreatic α-
amylase and intestinal α-glucosidase (Elsenhans and Caspary, 1987). A potential 
hyperglycemia treatment focuses on the inhibition of these enzymes, causing retardation 
in carbohydrate digestion and subsequently reducing glucose absorption rate into the 
bloodstream (Hillebrand et al., 1979).  
The present study aimed to determine the effect of conventional and low-glycinin soy 
cultivars on the protein profiles and antioxidant capacity of peptides generated by 
alcalase hydrolysis. The cultivars were grown in three different locations to identify 
which cultivar(s) exhibited the highest antioxidant capacity across multiple growing 
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regions after alcalase hydrolysis. The peroxyl radical scavenging antioxidant capacities of 
soy peptides were also compared against purified β-conglycinin and glycinin 
hydrolysates. Another part of the study was conducted to understand the effect of in vitro 
simulated digestion of protein-based beverages and ingredients on the production of 
peptides with potent antioxidant as well as α-glucosidase and α-amylase inhibitory 
activities. This research would highlight the importance of enzymatic hydrolysis of 
protein to improve antioxidant and antihyperglycemic potential.  
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CHAPTER 2 
LITERATURE REVIEW 
 
2.1 Soybean 
2.1.1 Biology of Glycine max (L.) Merrill 
Soybean [Glycine max (L.) Merr.], from the family Leguminosae, is an erect, bushy 
herbaceous annual which can reach 1.5 meters in height. It is planted when the weather 
gets warm during mid- to late May and requires 3-5 months for maturity (Bastidas et al., 
2008). It prefers a loose, well-drained, moist and nitrogen-rich soil with optimum 
temperature between 55 and 60°F for germination. Its reproductive growth starts after 
flowering and a period of pod or seed set (Egli, 2006). The flowers are self-pollinated and 
are about ¼ inch, white, pink or purple in color. The flowering period is around 40 days 
and the first seed pods appear approximately two weeks after the first flowers develop 
(Egli, 2006; NSRL, 2010). Nutrients produced by the leaves are later stored in the seeds, 
decreasing moisture content of the seed and causing morphology changes from large, 
kidney bean-shaped to small, nearly-round seed (NSRL, 2010).   
It is one of the oldest cultivated crops, originated from China around 11th century B.C 
(Hymowitz, 1970). It was first cultivated in the United States in 1765 and the growth of 
soybean industry was influenced by World War I when fats and oil were short in supply 
(Hymowitz and Harlan, 1983; Horan, 1974). Today, United States is the major producer 
of soybean, followed by Brazil, Argentina and China. The US Soy Crop Statistics 
estimated soybean cultivation to cover 31.4 million hectares which produced 91.5 million 
metric tons in 2009 (Soystats, 2010). The US is currently the world’s largest exporter of 
soybeans with 34.9 million metric tons exported, estimating an overall value of over 
US$21 billions (Soystats, 2010).  Among all the states, Iowa and Illinois were the first 
5 
 
and second largest producers with 13.2 and 11.7 million metric tons in 2009, respectively 
(Soystats, 2010).  
The geographical adaptation of soybean cultivars is determined by the time of 
flowering and maturity. According to the flower development, soybean cultivars can be 
separated into three groups: determinate, indeterminate and semi-determinate genotypes 
(Bernard and Weiss, 1973). Firstly, determinate genotypes, grown in the Southern United 
States, stop vegetative activity of the terminal bud when they achieve fluorescence at 
axillary and terminal racemes. Secondly, indeterminate types, cultivated in central and 
northern US, continue vegetative activity throughout the flowering period. Most 
commercial varieties are indeterminate which grow taller and better in short growing 
seasons. Finally, semi-determinate cultivars have indeterminate stems that terminate 
vegetative growth after the flowering period (Plant Biosafety Office, 1996).  
To determine areas of cultivar adaptation, photoperiod and temperature responses 
need to be considered carefully. Soybean cultivars have been categorized into majority 
groups (MG) that run east to west, within a narrow north-south geographical zone, 
determined by latitude and day length. As shown in Figure 1, Scott and Aldrich (1970) 
defined hypothetical zones of adaptation for 10 soybean maturity groups in the United 
States. The MG 00 represented the genotypes with the earliest maturity and MG VIII as 
the latest maturing genotypes.   
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Figure 1. Soybean maturity groups based on latitude of adaptation, adapted from Scott 
and Aldrich (1970). 
 
 
2.1.2 Soy processing and uses 
Soybean is mainly grown for the production of seed and holds a major role in food 
and industrial sectors. Soybean contains approximately 38% protein, 18% oil and 14% 
moisture (Pringle, 1974; Agriculture and Agri-Food Canada, 2001). Figure 2 shows a 
flow diagram of typical processing for the production of soy products. The basic steps 
include cleaning, cracking, dehulling, conditioning, flaking and extracting process. The 
soybean hulls can be used as a mill feed while the cracked soybeans are further flaked to 
produce soybean flakes. The flakes are extracted and go through a grinding process to 
form products such as soy flour, soy protein concentrate and isolate as well as soybean 
meal. On the other hand, crude soybean oils are also extracted from the soybean flakes 
which are further refined into three major soy oil-based constituents including shortening, 
lightly hydrogenated oil and bleached lecithin. Soybean processing brings various options 
to the food industry by allowing incorporation of soy-based ingredients into a broad 
variety of food products.  
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Figure 2. Flow chart of soy processing, adapted from NSRL, 2010. 
Soybeans 
Cleaning, Cracking, Dehulling 
Cracked Soybeans 
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and Isolate 
48% 
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Meal 
Refining 
Crude 
Lecithin 
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2.2 Protein hydrolysis 
2.2.1 Hydrolysis methodology 
Food intake is increasingly considered not only as a source of nutrients but also as a 
source of nutraceutical compounds such as bioactive peptides. Bioactive peptides consist 
of small amino acid sequences from proteins that have undergone hydrolysis or 
fermentation. The methods involved in the hydrolysis process are chemical (acid or 
alkali) and enzymatic. Acid hydrolysis requires the use of strong acids such as 
hydrochloric acid in combination with constant boiling at 110 °C for 24 h to break the 
peptide bonds. This hydrolysis is commonly employed in the development of flavor 
enhancers such as hydrolyzed vegetable protein (Dzanic et al., 1985; Velisek et al., 
1993). Alkaline hydrolysis also requires boiling at 100 °C for 8 hours in combination 
with 4 M sodium hydroxide for the reaction to occur (Methods in Biotechnology, 2009). 
The disadvantages of chemical hydrolysis include possible degradation of L-amino acids, 
production of D-amino acids, undesirable side reactions with non-protein components of 
the mixture and formation of toxic by-products such as lysinoalanine (Nakai, 1996; Lahl 
and Braun, 1994; Lahl and Grindstaff, 1989). Bucci and Unlu (2000) found that chemical 
hydrolysis reduces protein quality and nutritional value due to oxidation of cysteine and 
methionine, degradation of serine and threonine, and conversion of glutamine and 
asparagine to glutamate and aspartate, respectively. 
Enzymatic hydrolysis is considered a milder reaction than chemical hydrolysis and is 
a simulation of naturally-occurring hydrolytic process, breaking down large chain 
proteins into smaller peptides and amino acids. Proteolytic enzymes have extreme 
specificity in cleaving selected site of action which is a crucial aspect in determining the 
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functional properties of the hydrolysates. Another advantage of enzymatic hydrolysis is 
the ability to achieve the desired degree of hydrolysis, whereas the major drawback is the 
high cost to obtain the enzymes and control the extent of the reaction. Modern technology 
has developed ways to overcome these disadvantages. To reduce the cost of these 
enzymes, simple methods of enzyme preparation from readily-available raw materials are 
increasingly studied. Some examples of enzymes produced from industrial by-products 
are pepsin from stomach of Atlantic cod (Gildberg, 1992) and proteases from chicken 
intestine (Raju et al., 1997). In addition, enzyme can be immobilized to prevent its 
inactivation at the end of the hydrolysis, allowing repeated usage. The immobilization is 
done by chemical procedures or physical adsorption by attaching the enzyme to a solid 
support such as silica.  
2.2.2 Enzymes 
Godfrey and West (1996) reported that 40% of enzyme sales throughout the world 
could be attributed to the proteases of Bacillus spp., Mucor spp., and Aspergillus oryzae.  
Alcalase is a commercially available, industrial- and food-grade enzyme produced from a 
selected strain of Bacillus licheniformis. The main enzyme component is an 
endoproteinase, subtilisin Carlsberg. Ottesen and Svendsen (1970) found that it was 
capable of cleaving peptide bonds at Gln4-His5, Ser9-His10, Leu15-Tyr16 and Tyr26-Thr27. 
Protein hydrolysis of alcalase was usually performed at 50 °C with constant pH 8.0 for 3 
hours (Vaughn et al., 2008). 
The enzymes involved in human gastrointestinal digestion are pepsin and pancreatin.  
The in vitro digestion of proteins with pepsin pancreatin can generate bioactive peptides 
mimicking the physiological digestion in human. Pepsin requires an acidic environment 
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with optimum pH range of 1.8 to 3.2. Pepsin cleaves proteins at phenylalanine, tyrosine 
and leucine residues (Oka and Morihara, 1970; Trout and Fruton, 1969). Pancreatin 
represents proteases and peptidases secreted in the small intestine such as trypsin, 
chymotrypsin and carboxypeptidases (Adamson and Reynolds, 1995). The enzyme 
requires an optimum pH of 7.5 and catalyzes protein digestion into single amino acids or 
small peptides of up to 3 amino acids in length. The optimum temperature of these 
enzymes is the human body temperature of 37 °C (Megias et al., 2004). 
2.2.3 Food applications 
Food industry classifies protein hydrolysates and their applications based on the 
degree of hydrolysis (DH). Protein hydrolysates with DH lower than 10% improve the 
functional properties of common foods such as bakery products, ice cream and 
mayonnaise. Those with DH between 20 and 40% are utilized in the manufacturing of 
sauces, meats and soups due to their ability to enhance flavor profile. Those with DH 
higher than 40% are commonly manufactured into supplements and medical diets to treat 
certain diseases such as phenylketonuria (Pasupuleti and Anderson, 2008).  
However, one major limitation of protein hydrolysis is the formation of bitter 
peptides. This limits the incorporation of hydrolysates into dietary foods at high 
concentrations without producing undesirable taste. The bitter flavor is associated with 
the position of the hydrophobic amino acid residue in the peptide sequence (Kim and Li-
Chan, 2006; Matoba and Hata, 1972). The hydrophobic amino acid residues in intact 
proteins are supposed to be oriented towards the inner part of the molecule. Upon protein 
hydrolysis, hydrophobic-containing peptides will be released, leading to their interaction 
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with human taste buds (Matoba and Hata, 1972). The bitterness will increase as more 
hydrophobic amino acid residues are released during prolonged hydrolysis.  
 
2.3. Biological activities 
2.3.1 Soy bioactive compounds 
 
Table 1. Summary of bioactive compounds present in soy. 
Compounds  Description  Activities  References 
Isoflavones  3 major groups:  Antioxidant  Fritz, Seppanen, Kurzer  
  genistein, daidzein,    ab Csallany, 2003;  
  glycitein     Slavin et al., 2009 
 
Saponin  Oleanane   Anticancer  Zhang et al., 2009;  
  triterpenoids     Kim et al., 2004 
 
Lunasin  43 amino acid   Chemopreventive Dia et al., 2009 
residues;   
5.5 kDa   
 
Lectin   4 forms of  Anticancer   Abe et al., 1996;  
Isolectins     De Mejia and Prisecaru              
2005 
 
KTI   181 amino acid  Anticancer  Kobayashi et al., 2004 
residues;     
21.5 kDa  
 
BBI   71 amino acid  Treatment of  Birk, 1985; 
  residues;  inflammatory bowel Lichtenstein, 2008 
  7975 Da  diseases (ulcerative  
                                                            colitis)  
 
The public demand for soy products has been increasing in the recent years in 
response to their associated health benefits. Soybeans are rich in proteins, peptides and 
phytonutrients including β-conglycinin, glycinin, lectins, Kunitz Trypsin Inhibitor, 
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Bowman-Birk Inhibitor, lunasin, isoflavones and saponins, (Nielsen, 1996; Wang and de 
Mejia, 2005; Gonzalez de Mejia and Dia, 2009).  Several soy bioactive compounds and 
an example of their proposed health benefits are listed in Table 1. It is beyond the scope 
of our study to list all soy bioactive compounds and health benefits. Hence, the focus is 
emphasized on discussing soy β-conglycinin and glycinin hydrolysates. 
2.3.2 β-conglycinin 
Soybean contains a substantial quantity of proteins and the majority is associated to 
soybean storage proteins, trimer β-conglycinin and hexamer glycinin. Both account for 
50-70% of total seed proteins (Panthee et al., 2004). β-conglycinin is a glycoprotein 
which contains 4% carbohydrate of mostly mannose moieties. β-conglycinin has a 
molecular mass of 150-200 kDa with three major subunits α (about 67 kDa), α’ (about 71 
kDa) and β (about 50 kDa) (Liu, 1997). The α and α’ subunits are composed of core 
regions with a high degree of homology (90.4%) and extension regions exhibiting a lower 
homology (57.3%), whereas the β subunit is composed of only the core region that have 
75.5 and 76.2% homology with α’ and α core regions, respectively (Maruyama et al., 
1998). In response to pH and ionic changes, β-conglycinin undergoes association-
dissociation reaction. At neutral pH and ionic strength of >0.5, it is in the form of 7S 
globulin whereas at ionic strength of <0.2, it aggregates to form 9S globulin (Thanh and 
Shibasaki, 1979). The crystallized structure of soybean β-conglycinin α’-homotrimer is 
presented in Figure 3. 
β-conglycinin is a good source of bioactive peptides derived by enzymatic digestion. 
Beermann et al. (2009) reported that pancreatic trypsin/chymotrypsin hydrolysates of β-
conglycinin had significant radical scavenging properties. Chen et al. (1995) isolated six 
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antioxidative peptide fragments from digests of β-conglycinin. Martinez-Villaluenga et 
al. (2008) demonstrated that alcalase hydrolysates of soybean cultivars with increased β-
conglycinin content had higher inhibition rates of lipid accumulation in 3T3-L1 
adipocytes than hydrolysates with lower β-conglycinin content. Wang et al. (2008) 
showed that sequential pepsin pancreatin hydrolysis of β-conglycinin enriched cultivars 
resulted in lower IC50 values towards inhibition of L1210 leukemia cell growth compared 
to hydrolysis of cultivars with lower β-conglycinin content. Kuba et al. (2003) 
determined that peptide from α- and β- subunits of β-conglycinin, with amino acid 
sequence Ile-Phe-Leu, exerted angiotensin I-converting enzyme inhibitory activity. In 
addition, evidence showed that hydrolysates derived from β-conglycinin were protective 
ingredients and anti-microbial agents inhibiting the growth of Escherichia coli, 
Salmonella thyphimurium and Salmonella enteritidis (Shen et al., 2007; Yang et al., 
2008; Yang et al., 2008). 
 
 
Figure 3. Crystal structure of β-conglycinin α’-homotrimer (Maruyama et al., 2004). 
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2.3.3 Glycinin 
Glycinin has a molecular mass between 320-375 kDa with five major subunits 
A1aB2, A2B1a, A1bB1b, A5A4B3 and A3B4 (Nielsen 1996). Each subunit is composed 
of a basic (about 20 kDa) and an acidic (about 38 kDa) polypeptide (Statswick et al., 
1981) joined by disulfide bonds.  Each pair of both polypeptides is encoded by a single 
gene and cleaved post-translationally (Tumer et al., 1981). The solubility of glycinin in 
dilute Tris buffer is minimal around pH 5.5 (Thanh and Shibasaki, 1976) and between pH 
4.3 and 6.0 (Yagasaki et al., 1997). Glycinin molecular structure is affected by pH and 
ionic strength. At neutral pH and ionic strength of 0.5, glycinin is in the hexameric form 
of 11S globulin (360 kDa) (Badley et al., 1975). At ionic strength 0.01, glycinin 
disintegrates to form 7S globulin (Wolf and Brigs, 1958; Utsumi et al., 1987). The 
glycinin is also present in 7S globulin between pH 2.2 and 3.8 (Wolf et al., 1958) 
Secondary and tertiary unfolding (Koshiyama, 1972) have been observed at pH < 3. The 
crystallized structure of soybean glycinin A3B4 subunit is presented in Figure 4. 
Egusa and Otani (2009) found that glutamine-rich region of soybean glycinin G4 
subunit could act as immunomodulator which helped to prevent infectious diseases. 
Gouda et al. (2006) confirmed the antihypertensive property of hydrolysates derived from 
enzymatic digestion of glycinin using Protease P. In terms of functional properties, 
enzymatic hydrolysis of glycinin using pepsin played a role in improving the emulsifying 
activity. Tsumura et al. (2005) purified a peptide fragment from an acidic subunit of 
glycinin Ala which exhibited high emulsifying activity at pH 4.0. 
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Figure 4. Crystal structure of glycinin A3B4 subunits (Adachi et al., 2003).  
 
 
2.3.4 Isolation, purification and characterization of bioactive peptides from soybean. 
 The chemistry of β-conglycinin and glycinin has been widely studied and enzymatic 
hydrolysis of these proteins produces peptides with high nutraceutical values. Gonzalez 
de Mejia and Dia (2009) described the isolation, purification and characterization of 
peptides from soybean. Soybean seeds are first defatted and undergo size reduction 
before being extracted for naturally-occuring bioactive proteins and peptides. Another 
option is to perform enzymatic hydrolysis and/or fermentation to generate bioactive 
peptides. Protein purification can be performed based on differences in molecular weight, 
charge at certain pH and solubility characteristics. This can be done by combinations of 
chromatography, membrane separation and precipitation. After which the examination of 
purity and quantification of bioactive proteins and peptides can be done using SDS-
PAGE, Western Blot, HPLC or ELISA. The purified compound is finally characterized 
using MALDI-TOF, LC/MS-MS before testing its biological properties. 
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2.4. Antioxidant capacity 
2.4.1 Oxygen Radical Absorbance Capacity (ORAC) assay 
The ability of proteins to quench free radicals has been studied using different assays. 
The Oxygen Radical Absorbance Capacity (ORAC) assay has been gaining wide 
acceptance in the food industry (Hernandez-Ledesma, 2005). It can be utilized to measure 
the antioxidant activity in biological fluids, cells and tissues. This is done by measuring 
the loss of fluorescent marker, fluorescein over time due to peroxyl-radical formation 
generated by AAPH. Antioxidants suppress this reaction by a hydrogen atom transfer 
mechanism, inhibiting the oxidative degradation of fluorescein. A vitamin E analog, 
trolox, is used as a positive control inhibiting fluorescein decay in a dose dependent 
manner (Davalos et al., 2004). This is a kinetic assay measuring the antioxidant 
protection over time which can be normalized to equivalent Trolox units. The 
concentration of antioxidant is proportional to the fluorescence intensity which can then 
be assessed by comparing the net area under the curve (Prior and Cao, 1999). 
2.4.2 Soy antioxidant capacity 
Oxidative stress and the resulting tissue damage have been associated with multiple 
human diseases including diabetes mellitus and its complications (Baynes and Thorpe, 
1999). Proteins exert antioxidant properties by biologically designed mechanisms 
(antioxidant enzymes and iron-binding) or by nonspecific mechanisms. Antioxidative 
pathways of proteins include reactive oxygen species inactivation, free radical 
scavenging, metal chelation, hydroperoxide reduction, enzymatic elimination of oxidants 
and physical separation of reactive species.  
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Table 2. Examples of antioxidative peptides derived from soy proteins. 
Source   Preparation  Peptides  Reference 
Soy protein   Proteases from   Degree of hydrolysis Zhang et al., 2010 
isolate    Bacillus subtilis  ranged from  
   Bacillus licheniformis 22.6% to 25.1% 
 
Soy protein   Pancreatic  Peptides <1 kDa Beermann et al., 2009 
Isolate   trypsin   with aromatic 
      amino acids  
      residues 
 
Soy protein  Isoelectric points Acidic fraction  Park et al., 2008 
hydrolysate  (autofocusing)  basic fraction  
  
Native and heated Purified proteases: Degree of hydrolysis Pena-Ramos and  
soy protein isolate pepsin, papain,   ranged from   Xiong, 2002 
   chymotrypsin and 1.7% to 20.6% 
   crude proteases: 
   Alcalase, Protamex, 
   Flavourzyme 
 
β-conglycinin  Protease S from  LLPHH   Chen et al., 1996 
   Bacillus spp         
 
β-conglycinin  Protease S  (1) Val-Asn-Pro-His- Chen et al., 1995 
Asp-His-Gln-Asn  
(2) Leu-Val-Asn-Pro- 
His-Asp-His-Gln-Asn  
(3) Leu-Leu-Pro-His-His 
(4) Leu-Leu-Pro-His-His- 
Ala-Asp-Ala-Asp-Tyr  
(5) Val-Ile-Pro-Ala-Gly- 
Tyr-Pro (6) Leu-Gln- 
Ser-Gly-Asp-Ala-Leu- 
Arg-Val-Pro-Ser-Gly- 
Thr-Thr-Tyr-Tyr 
 
 
The antioxidant capacity of protein can be elevated by disrupting its tertiary structure 
through enzymatic hydrolysis. This increases the solvent accessibility of amino acid 
residues which exert free radical scavenging and metal chelation properties in 
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comparison to intact proteins (Elias et al., 2008). As reported in Table 2, proteins 
originating from soybean have been shown to demonstrate potent antioxidant activity 
upon enzymatic hydrolysis and/or fermentation process. 
 
2.5. Type 2 diabetes mellitus 
2.5.1 Overview 
Diabetes Mellitus (DM) is a chronic disease whose impact is increasing rapidly 
worldwide (Pasupuleti and Anderson, 2008). In 2007, the estimated number of people in 
the United States suffering from diabetes is 23.6 million or 7.8% of the population (CDC, 
2007). The two types of DM are type I insulin-dependent DM and type II non-insulin 
dependent DM. Type I DM occurs when human immune system destroys pancreatic β-
cells which are responsible in secreting insulin. Its management can be efficiently done 
through the continuous injection of insulin in timely dosages (WHO, 2009). Type II DM 
accounts for 90% of diabetic cases and typically begins as insulin resistance until the 
pancreas slowly loses its ability to produce insulin (Anderson et al., 2003). Recent shift in 
traditional consumption of low glycemic index (GI) foods to greater intakes of high GI 
foods leads towards epidemic growth of type II DM in North American population. Low 
GI foods such as pasta, cracked wheat or barley reduce carbohydrate absorption rate from 
the small intestine. Bertelsen et al. (1993) reported that reduced rate of absorption would 
lower postprandial glucose rise as well as the daily mean insulin levels, resulting in 
proper diabetes management. 
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2.5.2 Starch-hydrolyzing enzymes  
Increasing evidence shows that postprandial hyperglycemia is considered as the major 
determinant to the development of type 2 DM. The postprandial phase refers to rapid and 
large increase of glucose concentration in blood after a meal (Ceriello et al., 2005). It is 
fundamental to study the factors causing this elevation in blood glucose. The hydrolysis 
of dietary carbohydrates by pancreatic α-amylase and intestinal α-glucosidase is the main 
source of blood glucose (Elsenhans and Caspary, 1987). Therefore, the inhibition of these 
enzymes leads to retardation in carbohydrate digestion and subsequent increase in 
digestion time and reducing glucose absorption rate into the bloodstream (Hillebrand et 
al., 1979). α-glucosidase inhibitors are marketed as therapeutic drugs for postprandial 
hyperglycemia management that act through the inhibition of carbohydrate metabolism. α 
–glucosidase inhibition is believed to play a role in the rapid retardation of glucose 
absorption in blood.  
Glucosidase have the ability to catalyze the cleavage of glycosidic bonds in the 
digestive process of carbohydrates. α-glucosidase (EC 3.2.1.20) is an exo-type 
carbohydrase that catalyzes the liberation of α-glucose from the non-reducing end of the 
substrate. The enzyme is found in the brush border of the small intestines. The specificity 
of the carbohydrate digestive process is based on the number of monosaccharides, 
position of cleavage site and substrate hydroxyl group configuration (Kimura et al., 
2004). α-glucosidase I is derived from bacteria or yeast (Saccharomyces cerevisiae) 
which has higher activity towards heterogeneous substrates such as p-nitrophenyl α-
glucosidase (PNPG). α-glucosidase II is obtained from mold, plant and mammalian 
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sources that digests homogeneous substrates such as maltooligosaccharides faster than 
heterogeneous substrates (Kimura et al., 2004).  
α-Amylase (EC 3.2.1.1) is a digestive enzyme which speeds up the breakdown of α-
1,4-glucan bonds in starch, maltodextrins and maltooligosaccharides. This enzyme is 
commonly found in bacteria, animal, plants and fungi (Svensson, 1988). A partial 
digestion of starch is initiated by the salivary amylase which hydrolyzes polymeric 
substrate into shorter chain oligomers. Pancreatic α-amylase continues the hydrolysis 
process further down in the gut, forming maltose, maltotriose and small 
maltooligosaccharides.  The amylase secreted in the saliva and pancreas is encoded by 
the amy 1 and amy 2 gene, respectively. Human pancreatic amylase consists of a 496-
amino acid sequence and contains three structural domains, A, B and C (Nishide, 1986). 
The A domain is a barrel which contains the catalytic triad composed of Asp197, Glu223 
and Asp300. The B domain is bound to the A domain by calcium ion and is a large loop 
located between the third β-strand and the α-helix of A domain. On the other hand, the C 
domain is different from the other two domains as it is composed of β-strands.  
2.5.3 Acarbose structure, pharmacokinetics and mode of action 
The Food and Drug Administration has approved several pharmacologic drugs to 
manage the pathogenesis of diabetes (Pasupuleti and Anderson, 2008). Acarbose is one of 
the first of α-glucosidase inhibitors designed to control type 2 diabetes. It is a linear 
tetrasaccharide of α-D-glucose residues with the non-reducing end group having a double 
bond between C-4 and C-5 positions, and nitrogen replacing the interglycosidic oxygen 
atom (Figure 5A). Its systemic bioavailability is low with less than 2% of the unchanged 
drug gets absorbed and enters circulation after an oral administration (Medscape, 2002). 
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Most remains in the lumen of the gastrointestinal tract before being cleaved by bacterial 
enzymes in the large intestine. It is metabolized into absorbable intermediates such as 
glucose, maltose and acarviosine, before being excreted in the urine within 24 hours 
(Medscape, 2002).  
 
(A) 
 
(B) 
 
Figure 5. Acarbose chemical structure (A) and mechanism of action (B). 
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Acarbose mechanism of action is by binding to intestinal α-glucosidase and 
pancreatic α-amylase, thus incapacitating their carbohydrate-digesting ability (Figure 
5B). The inhibition of these enzymes leads to delay in carbohydrate digestion, prolonged 
digestion time, transport of undigested carbohydrates to lower intestinal parts and 
ultimately reducing the rate of glucose absorption into the bloodstream (Hillebrand et al., 
1979). However, acarbose causes complex carbohydrates to remain undigested in the 
intestine. Gut bacteria will ferment these carbohydrates leading to gastrointestinal side 
effects such as flatulence and diarrhea (Holman, 1999). This emphasizes the need to 
discover novel and natural α-glucosidase and α-amylase derived from dairy products, 
plants, fruits or vegetables with less pronounced side effects (Apostolidis et al., 2006; 
Deutschlander et al., 2009; Zhang et al., 2010; Mccue et al., 2005). 
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CHAPTER 3 
SIGNIFICANCE OF RESEARCH 
 
Global recognition of soy’s potential health benefits has recently gathered pace. Soy 
is one of the most cultivated agriculture crops grown in the United States and other parts 
of the world. Soy products have been gaining rapid penetration into the US market as 
shown by the growth in sales from $300 million in 1992 to $4 billion in 2008. Numerous 
studies have demonstrated that increased consumption of soy bioactive peptides is 
associated with increased antioxidant capacity while reducing the risk of chronic diseases 
such as diabetes mellitus, obesity, inflammation and cancer. This has led to the 
development of bioactive peptides through enzymatic hydrolysis for use as functional 
food ingredients or in the dietary supplement industry. Using plant breeding technology, 
growers have successfully developed a new line of soybean cultivars with high levels of 
β-conglycinin. Different levels of β-conglycinin content and growing locations affect the 
nutraceutical properties of soy, but limited studies have been conducted to study these 
effects on the antioxidant capacity of its protein hydrolysates. This study aims to 
determine a specific soybean cultivar that can be utilized to produce alcalase hydrolysates 
with high antioxidant capacity. Another part of the study will evaluate protein-based 
beverages and functional ingredients in terms of their antioxidant capacity and 
antihyperglycemic properties before and after pepsin pancreatin hydrolysis. This is to 
understand the potential to produce bioactive peptides, after in vitro gastrointestinal 
digestion, with high antioxidant capacity that can be used as potential therapeutic 
compounds to control postprandial hyperglycemia. 
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CHAPTER 4 
OBJECTIVE AND HYPOTHESES 
1. Objective 
The long term goal of this research was to determine the antioxidant capacity and 
antihyperglycemic property of protein hydrolysates in vitro. 
 
2. Central hypothesis 
Enzymatic hydrolysis of proteins will increase antioxidant capacity, as well as α-
amylase and α-glucosidase inhibitory activities due to the release of bioactive 
peptides.  
 
3. Specific aims 
Aim 1: To determine the effect of cultivar and growing location on the 
antioxidant capacity of alcalase hydrolysates and protein profiles of nine soybean 
cultivars grown in three different geographical locations.  
Hypothesis: Soybean cultivars and growing locations will affect the protein 
profiles and antioxidant capacity of bioactive peptides derived by enzymatic 
hydrolysis. 
1.1 To determine the protein profiles of two conventional and seven low-glycinin 
soy cultivars grown in three different locations. 
1.2 To perform enzymatic hydrolysis of two conventional and seven low-glycinin 
soy cultivars grown in three different locations using alcalase. 
1.3 To characterize the antioxidant capacity of soy protein hydrolysates against 
peroxyl radicals using ORAC assay. 
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1.4 To isolate and purify β-conglycinin and glycinin, as well as characterize the 
antioxidant capacity of their alcalase hydrolysates against peroxyl radicals. 
1.5 To study the effect of cultivar and location on soy protein profiles and 
antioxidant capacity of their hydrolysates. 
1.6 To evaluate the MALDI-TOF peptide mass profiles of soy protein 
hydrolysates. 
 
Aim 2: To determine the antioxidant capacity and starch-digestive enzymes 
inhibitory activity of protein-based beverages and selected functional ingredients 
pre- and post-pepsin pancreatin hydrolysis.  
Hypothesis: In vitro gastrointestinal digestion will increase the antioxidant 
capacity, as well as starch-digestive enzymes inhibitory activity of protein-based 
beverages and ingredients. 
1.1 To study the protein profiles of selected beverages and ingredients. 
1.2 To compare the antioxidant capacity of protein-based beverages and 
ingredients before and after pepsin pancreatin hydrolysis using ORAC assay. 
1.3 To evaluate the α-amylase and α-glucosidase inhibitory activities of protein-
based beverages and ingredients before and after pepsin pancreatin hydrolysis, in 
comparison to acarbose. 
1.4 To examine the MALDI-TOF peptide mass profiles of pepsin pancreatin 
hydrolysates of protein-based beverages and ingredients. 
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CHAPTER 5 
ANTIOXIDANT CAPACITY OF ALCALASE HYDROLYSATES AND PROTEIN 
PROFILES OF NINE SOYBEAN CULTIVARS GROWN IN THREE 
DIFFERENT LOCATIONS IN MIDWESTERN UNITED STATES 
 
5.1 Abstract 
Soy protein hydrolysates are now considered as a potential dietary source of natural 
antioxidants with important biological activities. This study was conducted to understand 
the effect of soybean cultivar and growing location on soybean protein subunit 
composition and antioxidant capacity (AC) of soy hydrolysates. Two conventional and 
seven low-glycinin soy cultivars were grown in Bloomington, IL, Findlay, OH and 
Huxley, IA. Soy protein hydrolysates were produced enzymatically by hydrolysis using 
alcalase. They were analyzed for AC and soluble protein using Oxygen Radical 
Absorbance Capacity (ORAC) and Detergent Compatible Protein assays, respectively. 
Statistical differences were observed in the protein profiles and AC among the different 
cultivars tested (p<0.05). Cultivars 1 and 6 had lower β-conglycinin (BC) subunits in 
comparison to the other cultivars. The hydrolysate of low-glycinin cultivar 3, enriched in 
β-conglycinin, from Bloomington exhibited the highest AC, compared to the other 
cultivars. Location appeared to have no effect on the soybean protein profiles and AC of 
soy protein hydrolysates. On average, AC for low glycinin soybean, high glycinin 
soybean and purified BC hydrolysates were not significantly different (p>0.05). Purified 
GL hydrolysate had an AC of 28.5 µM TE/µg soluble protein which was significantly 
different than low glycinin soybean hydrolysates (p<0.05). Our results showed the 
potential to perform alcalase hydrolysis on selected soy cultivars to produce natural 
antioxidant peptides for use as functional ingredients. 
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5.2 Introduction 
Research in bioactive compounds from agricultural products has increased due to a 
higher demand in natural supplements and nutraceutical foods to manage chronic 
diseases. Soybean, in particular, has been commonly recognized as a natural, functional 
food ingredient with exceptional nutritional value. Its consumption is associated with 
high antioxidant capacity (Amigo-Benavente et al., 2008) while lowering risk of diseases 
such as obesity (Anderson et al., 2007), hypertension (Shin et al., 2001; Nakahara 2010; 
Chen et al., 2009; Martin et al., 2008) and cancer (Kim et al., 2000). It has also become 
an important agricultural commodity as shown by the growth in sales of soy products 
from $300 million in 1992 to $4 billion in 2008 (Soy Foods Association, 2009).  
Bioactive peptides from soybean can be released from the protein matrix by human 
gastrointestinal digestion or food enzyme hydrolysis. Soy peptides produced from 
alcalase hydrolysis play a role in regulating body weight (Vaughn et al., 2008) and 
controlling lipid accumulation (Martinez-Villaluenga et al., 2008). The antioxidant 
capacity (AC) of soybean is also improved when intact protein is hydrolyzed into 
peptides (Elias et al., 2008). Upon hydrolysis, the amino acid residues are exposed, 
allowing them to assert strong AC. Several studies have demonstrated the AC of peptides 
derived from soy protein (Chen et al., 1996; Beermann et al., 2009; Park et al., 2008). 
Soy peptides have high oxidative inhibitory capacity due to their ability to scavenge free 
radicals and form a membrane around oil droplets, preventing the penetration of 
oxidation initiators (Hirose and Miyashita, 1999). Chen et al. (1998) concluded that 
histidine-containing soy peptides could serve as metal-ion chelators, oxygen quenchers 
and hydroxyradical scavengers. In addition, enzymatic hydrolysis of a major storage soy 
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protein, β-conglycinin, with protease S produced an antioxidant peptide with specific 
sequence leucine-leucine-proline-histidine-histidine (Chen et al., 1996). 
Cultivar, location and growing conditions play important roles in the production of 
bioactive compounds in agricultural crops. These parameters have been widely studied to 
optimize the AC of agricultural products such as berries (Connor et al., 2005; Howard et 
al., 2003), wheat (Moore et al., 2006) and spinach (Howard et al., 2002). A study was 
conducted by Riedl et al. (2007) to understand the effect these parameters had on the AC 
of isoflavone in soybeans. However, there are no studies regarding the effect of cultivars 
and growing locations on soybean protein profiles and AC of soy peptides. With the 
advancement in technology, soybean cultivars with different protein profiles can be 
selected to improve their biological activities (Bringe, 2006; Mohmoud et al., 2006).   
The objective of this research was to study the effect of conventional and low-
glycinin soy cultivars on the protein profiles and AC of peptides generated by alcalase 
hydrolysis. The cultivars were grown in three locations to identify cultivar(s) that exhibit 
high AC across multiple growing regions. In addition, the AC of soy peptides were 
compared against purified β-conglycinin and glycinin hydrolysates to determine if one of 
the major storage proteins contributes to higher AC than the other. The study then 
identified a specific soybean cultivar that showed high AC upon alcalase hydrolysis.  
5.3 Materials and Methods 
5.3.1 Materials 
5.3.1.1 Soybean samples 
Low-glycinin soybeans [Glycine max (L.) Merr.] with increased levels of β-
conglycinin were developed by the Monsanto Company (St Louis, MO). Two 
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conventional and seven low-glycinin soybean cultivars were grown in 2008 at three 
different locations: Bloomington, Illinois (B), Findlay, Ohio (F) and Huxley, Iowa (H). 
The planting dates for B, F and H were June 16th, May 24th and May 17th respectively. 
The latitude and longitude GPS coordinates for B were 40.45 and -89.15; for F 41.02 and 
-83.73; and for H 41.89 and -93.62, degrees. The plots at each location were two rows 4.5 
m long with 76 cm between rows. The seeding rate was 24 seeds m-1.  The seed from 
each plot was harvested in bulk with a self-propelled plot combine (ALMACO, Nevada, 
IA). The numbering of the samples is the same as originally provided by the Monsanto 
Company and the same nomenclature was maintained for consistency with other studies. 
Sample number 4 was not available and therefore not provided for this study. Defatted 
soy flour for the purification of β-conglycinin and glycinin were obtained from National 
Soybean Research Laboratory (Urbana, IL).  
5.3.1.2 Chemicals 
Mini-Protean TGX 4-20% precast gel, tricine sample buffer, 2-mercaptoethanol and 
precision plus protein standard for SDS-PAGE were purchase from Bio-Rad (Hercules, 
CA). Alcalase from Bacillus licheniformis (E.C. 3.4.21.62, 174 units/mg), Trolox (6-
hydroxy-2,5,7,8-tetramethylchroman-2 carboxylic acid)  and Bovine serum albumin 
(BSA) was purchased from Sigma-Aldrich (St. Louis, MO). Fluorescein [3’,6’-
dihydroxyspiro (isobenzofuran-1[3H],9’[9H]-xanthen)-3-one] was purchased from 
Fisher Scientific (Hanover Park, IL). AAPH [2,2’-azobis(2-amidinopropane) 
dihydrochloride] was purchased from Aldrich (Milwaukee, WI). All other chemicals, 
unless otherwise specified, were purchased from Sigma-Aldrich (St. Louis, MO).  
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5.3.2 Preparation of defatted soy flour 
Soybean samples (150 g) were grounded twice through a Thomas-Wiley model 4 mill 
(Thomas-Wiley, Swedesboro, NJ) with a 2 mm screen. Ground materials were then 
reground in the same mill using a 1 mm sieve. Samples were extracted using hexane with 
traditional Soxhlet extractor. Aliquots of approximately 25 g were extracted for a 
minimum of 5 h. Extracted samples were then air dried for 2-3 h at room temperature. 
5.3.3 Protein extraction from defatted soy flour 
The extraction procedure consisted of placing 0.05 g of the defatted soy flour and 1 
mL of the extracting buffer (0.05 M Tris-HCL buffer, pH 8.2) in an Eppendorf tube. 
After the mixture was mixed, the samples were placed in an ultrasonic bath (Bransonic 
model 2510, Bransonic Ultrasonic Corporation, Danbury, CT) for 70 min, mixing again 
every 10 min to avoid settlement. The temperature of the water bath was controlled at 40 
°C by using a recirculating bath (Endocal model RTE-9, Neslab Instruments, Portsmouth, 
NH). Following extraction, the samples were centrifuged at 20,000g for 30 min at 4 °C in 
an Eppendorf Centrifuge (model 5417R, Brinkmann Instruments, Westbury, NY), and the 
obtained supernatant was transferred to an Eppendorf tube. 
5.3.4 Purification of β-conglycinin (BC) and glycinin (GL) from defatted soy flour 
BC and GL were purified by following the published procedures with some 
modification (Wang et al., 2008). One hundred grams of defatted soy flour was 
suspended in 1.5 L of distilled H2O and the pH adjusted to 7.5 with 2 N NaOH. The 
solution was centrifuged at 9000g for 30 min. For GL purification, sodium bisulfite 
(SBS) (0.98 g/L) was added to the supernatant and the pH was adjusted to 6.4 with 2 N 
HCl. It was then stored overnight at 4 °C and centrifuged at 6500g for 20 min at 4 °C. 
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The precipitate was washed with 40 mL of ice-cold distilled H2O and labeled as purified 
GL. For BC purification, the first step was similar to GL purification except the pH was 
adjusted to 5.9 to obtain high-purity BC. After centrifugation, NaCl was added to the 
supernatant to make a salt concentration of 0.25 M, and the pH was adjusted to 5.0 with 2 
N HCl. After 1 h of storage at 4 °C, the supernatant was collected after centrifugation at 
9000g for 30 min at 4 °C. Two volumes of ice-cold distilled H2O were added to the 
supernatant and the pH adjusted to 4.8 with 2 N HCl. The precipitate was collected from 
6500g for 20 min at 4 °C and washed twice with 40 mL of cold distilled H2O. Then it 
was suspended in 25 mL of water and pH adjusted to 7.5. This was designated purified 
BC. Both purified BC (>80% purity) and GL (>97% purity) were lyophilized and stored 
at -70°C for further analysis. 
5.3.5 Preparation of soy protein hydrolysates with alcalase  
Defatted soybean flour, pure β-conglycinin and glycinin were hydrolyzed by 
treatment with alcalase according to Vaughn et al. (2008). Briefly, 4 g of defatted 
soybean flour were suspended in 50 mL deionized water and brought to 50 °C at pH 8.0. 
Once temperature and pH were maintained, 5.3 mg of alcalase (E.C. 3.4.21.62, 174 
units/mg) were added and hydrolysis was carried out for 3 h. The temperature and pH 
were maintained using a waterbath and 0.5 M NaOH, respectively. The hydrolysis was 
stopped by the addition of 150 µL of 0.1 N HCl. Hydrolysates were centrifuged at 
14,000g at 10 °C for 30 min. After centrifugation, non-acid soluble substances were 
removed by the addition of 10% trichloroacetic acid (TCA) in 1:1 ratio. The hydrolysates 
were centrifuged again under the same conditions to remove precipitates. The pH of the 
liquid hydrolysates was adjusted to 7.0 before being concentrated by ultra-filtration using 
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3,000 Da MWCO membrane (Millipore) to remove salts from the mixture. The 
hydrolysates were freeze dried in a FreeZone freeze dry system (Kansas City, MO).  
5.3.6 Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
analysis of defatted soy flours, purified β-conglycinin and glycinin  
Proteins extracted from samples were mixed with sample loading buffer [950 μL 
Laemmli SDS buffer (Biorad, 161-0737) and 50 μL 2-mercaptoethanol] with a 1:1 ratio. 
A sample of 20 µg of total protein was run on a 10 lane 4-20% Tris-HCL Bio Rad Ready 
Gels. The gels were then fixed with 40% methanol and 10% acetic acid for 20 min. Next, 
they were stained with Colloidal Coomassie Blue G-250 overnight. They were destained 
in 10% acetic acid for 30 min, and imaged using the GS 800 Calibrated Densitometer 
(Bio-Rad Laboratories, Hercules, CA). Determination of the molecular weight of protein 
bands was confirmed by comparing theoretical molecular weights with experimental 
data.  
5.3.7 Peptide mass mapping by Matrix-Assisted Laser Desorption Ionization Time-
of-Flight (MALDI-TOF) 
Five selected hydrolysates from Findlay cultivars as well as purified BC and GL 
hydrolysates were analyzed by MALDI-TOF using an Applied Biosystems Voyager-DE 
STR (Foster City, CA, USA) for molecular mass peptide mapping. The following 
parameters were used in the analysis: linear mode of operation, positive polarity and 500-
20,000 m/z scanning range. 
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5.3.8 Measurement of antioxidant capacity by the Oxygen Radical Absorbance 
Capacity (ORAC) assay 
The oxygen radical absorbance capacity assay (ORAC) was adapted from published 
methods (Prior et al., 2003; Davalos et al., 2004). Fluorescein and AAPH solutions were 
prepared using 75 mM phosphate buffer, pH 7.4.  In triplicate (20 µL), samples and 
Trolox standard dissolved in 75 mM phosphate buffer at concentrations ranging from 4 
µM to 150 µM,  or 75 mM phosphate buffer blank were added to a 96-well black walled 
plate; after which, 120 µL Fluorescein was added and incubated for 15 min at 37˚C.  
After incubation 60 µL AAPH was added before reading immediately in a fluorescent 
FLx800tbi Synergy 2 multi-well plate reader, (BioTek, Winooski, VT), at 37˚C, 
sensitivity 60, read every 2 min for 120 min with excitation at 485 and emission at 528 
nm. Fluorescein reacted with the free radicals generated by AAPH to generate a non-
fluorescent product.  Loss of fluorescence was measured over time and the area under the 
curve (AUC) was calculated. Results were expressed as µmol Trolox equivalents (TE)/g 
flour. 
5.3.9 Soluble protein measurement by Detergent Compatible (DC) protein 
quantification assay 
Soluble protein was quantified by the DC Protein Microplate Assay™ protein assay 
(Bio-Rad, Hercules, CA) based on the Lowry (Folin) assay as described by Dia et al. 
(2009). The procedure consists of adding 5 μL of samples or bovine serum albumin 
(BSA) for the construction of standard curve in the range 10–1600 μg/mL. After which, 
25 μL of reagent A was added and 200 μL of reagent B was added followed by 15 min 
incubation at 25 oC. The absorbance was read at 630 nm using a 96-well plate reader 
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(Biotek Instruments, Winooski, VT). Total soluble protein concentration of the fractions 
from affinity chromatography and soybean products were quantified based on the BSA 
standard curve (y = 0.0002 x - 0.007, R2 = 0.99).  
5.3.10 Experimental design 
 
 
Figure 6. Experimental design to determine the antioxidant capacity of alcalase 
hydrolysates and protein profiles of nine soybean cultivars grown in three different 
locations. 
 
5.3.11 Statistical analysis 
The statistical analysis was conducted using SAS version 9.1.3 (SAS Institute Inc., 
Cary, NC, USA). Statistical differences were tested by two-way analysis of variance 
(ANOVA) using the proc General Linear Models (GLM). Means were considered to be 
different at a significance level of ≤ 0.05. Data was expressed as means of at least three 
replicates. Principle Component Analysis (PCA) was conducted to detect important 
factors of variability and to describe the relationship between variables and observations. 
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Data were presented in terms of factor loading of the corresponding variables on the 
observed factors. 
5.4 Results and Discussion 
5.4.1 Characterization of soybean cultivars, glycinin and β-conglycinin  
The chemical composition of soybean seed depends on varieties and environmental 
conditions such as water stress and temperature (Rotundo and Westgate, 2009). The nine 
cultivars used in this study contained protein, lipid and moisture values ranged from 
36.4% - 42.2%, 17.8% - 23.6% and 6.4% - 8.8%, respectively, as shown in Table 3. 
These values are similar to a previous study by Pringle (1974) showing the average 
composition of protein, lipid and moisture to be 40.5%, 20.5% and 6.6%, respectively. 
 
Table 3. Moisture, lipid and protein (%) of nine soybean flours prepared from the nine 
cultivars grown in three locations.* 
 
Cultivar Moisture (%) Lipid (%) Protein (%) 
  B F H B F H B F H 
1 8.0 7.7 7.8 23.6 22.9 21.0 37.1 38.5 39.3 
2 8.3 7.1 7.6 21.2 19.4 17.8 37.1 41.3 40.9 
3 8.7 8.3 8.5 20.2 19.2 17.9 39.3 41.6 41.7 
5 8.1 7.4 8.3 23.2 20.5 19.4 36.8 42.0 41.7 
6 7.2 6.4 7.2 20.7 20.4 19.5 40.5 41.0 40.2 
7 8.2 7.9 8.4 20.8 20.0 18.5 39.3 40.7 41.1 
8 7.4 6.8 7.3 22.7 21.4 20.0 36.4 38.7 38.6 
9 8.7 8.6 8.8 21.6 20.3 18.8 37.1 40.4 40.2 
10 8.6 8.2 8.4 19.7 18.6 17.9 40.6 42.2 42.0 
*There values were expressed as wet basis and were not statistically different within each 
parameter (p > 0.05). B=Bloomington; F=Findlay; H=Huxley. 
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The major storage proteins present in soybean are trimer β-conglycinin (BC) and 
hexamer glycinin (GL) which account for 50-70% of total seed proteins (Panthee et al., 
2004). BC has a molecular mass of 150-200 kDa with three major subunits α, α’ and β 
(Liu, 1997); whereas the molecular mass of GL is between 320-375 kDa with five major 
subunits A1aB2, A2B1a, A1bB1b, A5A4B3 and A3B4 (Nielsen et al., 1996). Figure 7 
depicted the SDS PAGE electrophoretic profiles of purified β-conglycinin and glycinin at 
different concentrations. Lanes 2, 3 and 4 had three major bands representing the A3 
chain, A1,2,4 chain and basic chains of glycinin, whereas lanes 6, 7, 8 showed three 
strong bands representing α’, α and β subunits of β-conglycinin. The identities of these 
protein bands agreed with previously reported studies (Martinez-Villaluenga et al., 2008; 
Wang et al., 2008; Hou and Chang, 2004).  
 
  
Figure 7. Protein profiles of purified glycinin and β-conglycinin from soybeans. The 
standards were represented by lane 1 and 5, whereas the other lanes depicted the 
protein:water ratio of glycinin and β-conglycinin. 
α’ subunit 
α subunit 
β subunit 
A3 chain 
A1,2,4 chain 
Basic chain 
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Cultivars from Findlay were were characterized using SDS-PAGE electrophoresis. 
As shown in Figure 8, the gel showed six major protein bands corresponding to BC 
subunits (α, α’ and β) ranging from 45 to 67 kDa and GL subunits (A1, 2, 3, 4, and basic 
chains) ranging from 20.5 to 38.5 kDa. Cultivars 1F and 6F showed intense bands on 
A1,2,4 chain (35 kDa) and basic chain (20.5 kDa) of GL, whereas the rest of the cultivars 
had more intense bands on α chain (60 kDa) and α’ chain (65 kDa) of BC.  
 
 
 
Figure 8. Protein profiles of soy flours from nine soy cultivars from Findlay. 
 
 
In the present study, the total BC and GL content of all soybean cultivars ranged 
from 25.9 to 56.9% and 0.7 to 42.8%, respectively (Table 4). Cultivars 1 and 6 from three 
locations exhibited the highest total GL among the nine soybean cultivars. Growing 
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locations did not affect the protein profiles of the soybean samples (p>0.05). Table 5 
showed the percent distribution of each protein subunit from the nine cultivars and three 
growing locations. Among different cultivars, GL subunits varied; for example A3 chain 
ranged between 0.0 and 6.9%; A1,2,4 chains between 0.4 and 19.2%; and basic 0.0 and 
20.2% of total protein. Cultivar 2, 3, 7, 8, 9, 10 lacked the GL subunit A3, whereas 
cultivar 5 had the highest A3 subunit (~6.6%). Cultivar 6 had the highest content in 
A1,2,4 subunit of GL with an average of 18.7% across three locations. The average of 
basic GL content was highest in cultivar 1 and 6 with about 19.2 and 19.7% across three 
locations, respectively. BC subunits also varied among cultivars, the range of α' was 
between 8.9 and 20.2%, α between 13.3 and 28.2% and β subunit between 3.6 and 
13.4%. Cultivar 1, 5 and 6 had the lowest content in α' subunit of BC. The α subunit 
content was lowest in cultivar 1, 5 and 6 except for 5B. Cultivars 5H, 9F, 10B and 10H 
had the highest content in β subunit of BC. These results demonstrated that the cultivars 
provided a distinct spectrum of subunit compositions which allow cultivar selection with 
the highest biological activities, for example antioxidant capacity.  
5.4.2 Soy protein, β-conglycinin and glycinin hydrolysates 
The ORAC assay determines antioxidant capacity by measuring the scavenging 
activity of peroxyl or hydroxyl radicals (Davalos et al., 2004). The assay also measures 
the degree of inhibition and inhibition time before combining both parameters into a 
single quantity using an area-under-the curve calculation (Prior and Cao, 1999). The 
measurement of antioxidant capacity of food products using ORAC assay can be 
standardized and compared across different research laboratories (Zulueta et al., 2009). 
Figure 9 illustrated the loss of fluorescence curve of soy hydrolysates from three cultivars 
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grown in Huxley, IA in comparison to trolox and a synthetic antioxidant, BHT (1 mg/ml). 
It was observed that variation in antioxidant capacity existed among different soy protein 
hydrolysates, with a curve shifting more to the right indicating a stronger antioxidant 
power in quenching the peroxyl radicals. This suggested that the three soy protein 
hydrolysates (1H, 2H and 3H) had higher antioxidant capacity than BHT. 
 
Table 4. Effect of cultivar and location on total protein profiles of β-conglycinin (BC) 
and glycinin (GL) and soluble protein of alcalase hydrolysates.  
 
Cultivar      Location β-conglycinin(%) Glycinin(%) Soluble Protein (mg/mL)   
1  B 28.2   39.6*  18.0 ±1.7a    
 F 28.8   39.6*  15.0±0.3d,e,f,g,h   
 H 29.3   41.0*  14.8±1.0e,f,g,h,i   
2  B 50.4*   3.2  15.2±0.3d,e,f,g   
F 51.1*   5.0  14.0±0.0i,j,k,l   
 H 52.6*   4.3  14.8±1.2e,f,g,h,i   
3  B 48.1*   4.0  14.2±0.3h,i,j,k   
 F 51.4*   5.8  14.4±0.6g,h,i,j,k   
H 55.0*   5.5  11.8±0.6n   
5  B 49.4*   14.2  14.4±0.0g,h,i,j,k    
 F 47.3*   16.9  14.6±0.0f,g,h,i,j    
 H 47.6*   17.8  15.8±0.3c,d    
6  B 25.9   41.6*  16.4±0.3b, c              
 F 29.0   41.2*  15.0±0.7d,e,f,g,h   
 H 26.1   42.8*  14.4±0.3g,h,i,j,k   
7  B 49.9*   4.3  16.8±0.6b    
 F 56.3*   5.7  13.2±0.0l,m    
 H 51.0*   5.0  14.4±0.7g,h,i,j,k    
8  B 51.8*   3.4  16.4±0.7b, c          
 F 52.5*   1.5  15.4±0.9d,e,f    
 H 53.5*   3.4  14.8±0.0e,f,g,h,i   
9  B 53.6*   4.2  15.6±0.6c,d,e    
 F 52.8*   8.1  13.2±0.6l,m    
 H 54.3*   0.4  14.2±0.0h,i,j,k   
10  B 56.8*   6.2  13.6±0.3k,l   
 F 55.0*   3.5  13.8±0.0j,k,l   
 H 52.4*   4.9  12.6±0.3m,n   
a B=Bloomington; F=Findlay; H=Huxley; b Results from non-hydrolyzed soybean; c The 
soluble protein and ORAC value of hydrolysate was expressed in µgram per µmL and µmol 
Trolox Equivalents per gram of flour, respectively. The values mean, followed by the same 
letter(s) are not significantly different (P > 0.05) 
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Table 5. Protein profiles of β-conglycinin (BC) and glycinin (GL) subunits in nine 
soybean cultivars grown in three different locations. 
 
   β-conglycininb   Glycininb 
Cultivar   Locationa % α’ % α % β  % A3 % A1,2,4 % Basic 
1        B  9.7 14.8 3.8  3.1 17.3  19.3* 
F  9.3 14.3 5.1  3.6 17.0  19.0* 
H  9.5 14.8 5.1  3.4 18.5*  19.2* 
2        B  19.6* 25.8* 5.0  0.0 1.4  1.8 
       F  19.6* 25.2* 6.3  0.0 2.3  2.7 
H  19.8* 25.4* 7.5  0.0 2.2  2.1 
3        B  18.4* 23.7* 6.0  0.0 1.7  2.3  
F  19.7* 24.1* 7.6  0.0 2.9  2.9         
H  20.2* 25.9* 9.0  0.0 2.8  2.7 
5        B  15.5 22.8* 11.1  6.3* 1.8  6.1 
F  15.6 21.1 10.6  6.9* 2.4  7.5 
H  15.0 21.0 11.7*  6.7* 2.9  8.3 
6        B  8.9 13.4 3.6  3.2 18.4*  20.0* 
F  9.6 14.4 5.1  3.7 18.5*  19.0* 
H  9.1 13.3 3.7  3.4 19.2*  20.2* 
7        B  18.0* 24.2* 7.8  0.0 2.1  2.2 
F  18.6* 28.2* 9.5  0.0 2.8  2.9 
H  18.1* 24.7* 8.2  0.0 2.3  2.7 
8        B  18.3* 24.0* 9.6  0.0 1.5  1.9  
F  18.7* 24.5* 9.2  0.0 0.5  1.0  
H  19.0* 24.3* 10.1  0.0 1.6  1.8 
9        B  19.1* 24.9* 9.7  0.0 2.0  2.2 
F  17.1* 23.8* 11.9*  0.0 3.9  4.3 
H  19.7* 25.7* 8.9  0.0 0.4  0.0 
10        B  18.9* 24.6* 13.4*  0.0 3.2  3.0 
F  19.0* 26.3* 9.6  0.0 1.4  2.1 
H  17.1* 22.9* 12.5*  0.0 2.7  2.2  
* indicates highest values (P<0.05)  
a B=Bloomington; F=Findlay; H=Huxley 
b Percentage of total protein 
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Figure 9. Loss of fluorescence curves for soy hydrolysates from cultivars grown in 
Huxley in comparison to a known antioxidant, BHT. 
 
 
The ability of protein to behave as antioxidants in radical-mediated oxidation 
reactions was attributed to their ability to trap free radicals (Neuzil, 1993). The ORAC 
values of 27 soy protein hydrolysates are shown in Figure 10. All hydrolysates showed 
notable AC which ranged from 57.0 to 81.1 µmol TE/g flour (p<0.05). The hydrolysates 
from cultivar 3B showed the highest AC (81.1 µmol TE/g flour), followed by the cultivar 
8H, 3H and 3F (75.0, 74.5 and 74.3 µmol TE/g flour, respectively). Cultivar 3 was 
selected as a raw material for soymilk production to be used in a separate, on-going 
human study. The cultivar with the lowest AC was cultivar 9H and 9F with 57.0 and 57.1 
µmol TE/g flour, respectively.  
As a comparison, Slavin et al. (2009) measured the AC of non-hydrolyzed yellow 
soybean (genotypes MD 05-6073, MD 06-5433-1 and MD 06-5445-5) to have less than 
40 µmol TE/g using ORAC assay. In addition, Xu et al. (2007) reported the ORAC 
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values of Proto (yellow), Korada (yellow) and Tofuyi (yellow) soybeans to be 36.9, 44.2 
and 35.1 µmol TE/g, respectively. These proved that protease digestion of soybean 
enhanced antioxidant efficacy due to production of antioxidant peptides as supported by 
previous findings (Chen et al., 1996; Beermann et al., 2009; Park et al., 2008; Elias et al., 
2008). Previous researches have also recorded significant AC of non-soy protein 
hydrolysates and other dietary peptides (Manso et al., 2008; Hogan et al., 2009).  
Table 6 showed a list of peptide masses determined by MALDI-TOF-MS of protein 
hydrolysates from different soybean cultivars grown in Findlay, pure BC and GL. 
Cultivar 2F had strong signals at m/z 658, 1293, 1538, 1669, 1700, 2835 and 3386. 
Cultivar 5F showed high signals at m/z 658, 674, 1669 and 3386. Cultivar 10F was 
characterized by intense peaks at m/z 544, 658, 674, 1526, 1669, 3386 and 3903. The 
MALDI-TOF-MS peptide mass profiles of cultivars 3F and 9F, representing the cultivars 
with the most and least AC, were reported in Figure 11(A) and (B), respectively. The 
peaks were selected by spectrum intensity and cultivar 3F showed a distinct signal 
(100%) at m/z 3385. As shown in Appendix B.2, this signal (3385 m/z) was a peptide 
fragment from β-conglycinin. This is in agreement to a previous study conducted by 
Gonzalez de Mejia et al. (2009). On the contrary, cultivar 9F showed a signal at 3385 
m/z with only 40% intensity. Furthermore, Beermann et al. (2009) reported a peptide 
from β-conglycinin with a mass of 547 m/z to exhibit radical scavenging properties. 
Cultivar 3F presented that specific signal with an intensity of 20%, whereas cultivar 9F 
did not exhibit any signal for this peptide. In the future, isolation of these peptides and 
identification of their amino acid sequences will be necessary to explore its antioxidant 
mechanism.   
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Figure 10. Effect of cultivar and location on antioxidant capacity (µmol trolox equivalent/g flour) of soy protein hydrolysates. Bars 
are X ± SD. Different superscript letters indicate statistically different values among the cultivars at p < 0.05.
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Table 6. Peptides masses detected in alcalase hydrolysates from five soybean cultivars 
grown in Findlay, OH, purified β-conglycinin (BCH) and glycinin (GLH) by MALDI-
TOF-MS* 
 
 
 
 
 
Peptide Mass  
(Da) 1F 2F 3F 5F 10F BCH  GLH 
544.2 xx x x x xx   
658.2 xx xx xx xxx xxx   
674.3 x x xx xx xx   
1293.1 x xx x x x   
1526.8  x x x xx x  
1538.2 xx xx x x x   
1669.2 xxx xxx xx xx xx  x 
1700.4 x xx x x x x  
1754.4 x      xxx 
1796.7  x  x x x  
1972.0 x      xxx 
2706.1 x x x x x x  
2746.6 x      x 
2769.9   x    x 
2835.5 x xx xx x x   
3177.7 x      x 
3229.0   x x x x  
3386.5 xxx xxx xxx xxx xxx xxx  
3545.0  x x x x x  
3829.1 x x x x x x  
3903.0 x x x x xx xx  
5028.8 x x x x x x  
5543.1 x x x x x x   
* Peptide masses found in soybean hydrolysates, purified β-conglycinin (BCH) and glycinin (GLH) 
hydrolysates with intensities < 40% are indicated with ‘x’; peptides masses with intensities between 
40-70% are indicated with ‘xx’ and peptides masses with intensities > 70% are indicated with ‘xxx’. 
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(A)       
 
 
(B) 
 
 
Figure 11. MALDI-TOF spectrums of cultivar 3 (A) and cultivar 9 (B) hydrolysates from 
soybeans grown in Findlay using the following parameters: linear mode of operation, 
positive polarity and 500-20,000 Da scanning range.  
 
 
As shown in Appendix B.1, the average AC for low glycinin soybean, high glycinin 
soybean and purified BC hydrolysates were not significantly different (p>0.05). Purified 
GL hydrolysate had an AC of 28.5 µM TE/µg soluble protein which was significantly 
different than low glycinin soybean hydrolysates (p<0.05), although statistically similar 
3385 m/z 
547 m/z 
3385 m/z 
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to high glycinin soybean and purified BC hydrolysates. One possible explanation was 
that BC was more susceptible to protease hydrolysis, increasing the production of 
peptides, in comparison to GL (De Reu et al., 1995; Kim et al., 1990). Romagnolo et al. 
(1990) stated that disulfide links, which connected acidic and basic subunits of GL, were 
buried in the interior part of molecules, decreasing protease hydrolysis reactions. In 
addition, the hydrophobic association and compactness of GL structure played a role in 
decreasing the rate of hydrolysis.  
 
5.4.3 Effect of cultivar and growing location on β-conglycinin and glycinin subunits, 
as well as antioxidant capacity of soy protein hydrolysates 
The current study showed significant effect of cultivars (p < 0.05) on the AC of soy 
protein hydrolysates. Across all locations, the AC in nine cultivars ranged from 59.0 ± 
3.4 to 76.6 ± 3.9 µmol TE/g flour (Figure 12). As shown in Table 7, there was also a 
significant effect of cultivar-location interaction (p < 0.05). For example, cultivar 1B 
exhibited significantly higher AC than cultivar 1F but cultivar 10B had significantly 
lower AC than 10F. Although Huxley was wet all season whereas Findlay and 
Bloomington started wet and cool and ended dry with normal temperatures, locations did 
not show a significant effect on AC. As reported in Figure 13, all locations yielded soy 
protein hydrolysates with similar AC (p>0.05). The average AC of hydrolysates from 
soybeans grown in Huxley, Bloomington and Findlay were 67.3 ± 6.1, 66.5 ± 6.6 and 
65.8 ± 7.0 µmol TE/g flour, respectively. This was probably due to the fact that all 
experimental locations were in the Midwestern United States and therefore the 
environmental conditions were not drastically different. 
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Figure 12. Average ORAC values (µmol trolox equivalent/g flour) of soy protein 
hydrolysates as affected by cultivar. Bars are X ± SD. Different superscript letters 
indicate statistically different values among the cultivars at p < 0.05. 
 
 
 
 
 
Figure 13. Average ORAC values (µmol trolox equivalent/g flour) of soy protein 
hydrolysates as affected by location. Bars are X ± SD. Same superscript letters indicate 
statistically similar values among the cultivars at p > 0.05. 
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Table 7. Analysis of variance of antioxidant capacity of alcalase hydrolysates of nine 
soybean cultivars grown in three different locations. 
 
Source DFa Type III SSb  Mean Square  F Value Pr>Fc 
Cultivar 8 1846.4   230.8   15.0  <.0001 
Location 2 30.3   15.2   1.0  0.3819 
Cult*Loc 16 695.7   43.5   2.8  0.0024 
a DF = Degrees of freedom; b Type III SS = Sum of squares; c Significant at the 0.05 
probability level 
 
 
PCA was used to assess the effects of the soybean cultivar and growing location on 
the AC of alcalase hydrolysates and protein profiles of soybean cultivars. It is known in 
PCA analysis that an eigenvalue greater than 1 corresponds to a significant effect on a 
component (PC1 = 4.8 and PC2 = 1.2). The highest explained variance, PC 1, was 
associated with BC and GL subunits which accounted for 68.3% of explained variance, 
while PC 2 was associated with AC, with an explained variance equaled to 17.4% (Figure 
14). The two PCs accounted for 85.7% of the total variance explained. Cultivars 1 and 6 
from all locations showed obvious separation along the positive side of the x-axis, while 
most of the other cultivars were on the negative side. The two cultivars were separated on 
the horizontal axis of PC 1 because of their high concentrations of GL subunits in 
comparison to the other cultivars. Cultivar 5 from all locations was located close to the 
center on PC 1 axis and did not appear to be dominated by either BC or GL subunits. The 
dispersion of soybeans along PC 2 axis was a function of AC. Cultivar 3 from all 
locations was loaded on the upper, positive-half of PC 2, indicating that this cultivar had 
the highest association with AC. 
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Figure 14. PCA of nine soybean cultivars from three different locations. Loadings plots for 
the first two principal components and its respective percentage of variance. 
B=Bloomington; F=Findlay and H=Huxley. 
 
Table 8 illustrated the Pearson correlation coefficients between moisture, fat, protein, β-
conglycinin (subunits), glycinin (subunits) and ORAC values. The levels of α and α’ BC 
subunits were negatively correlated with A 1, 2, 4 and basic GL subunits concentrations (r2 = 
<0.96, P < 0.05). As the total level of BC increased, the total GL level decreased 
significantly. This outcome demonstrated the possibility to develop soybean lines with high 
BC and low GL levels through breeding programs. In addition, it was interesting that ORAC 
values were positively correlated only with α and α’ BC (r2 = 0.29 and 0.20, respectively, 
P<0.05 respectively). Beta BC and all GL subunits had an inverse correlation with ORAC 
values.  
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Table 8. Pearson correlation between soybean composition and ORAC Value a. 
 
a Data are expressed as Pearson correlation coefficient (R2). A positive R2 indicates a positive linear correlation, and a negative slope 
indicates a negative linear correlation. Bold values indicate a correlation greater than 0.30, representing moderate to strong effect. BC, 
β-conglycinin; GL, glycinin; ORAC, oxygen radical absorbance capacity. 
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The study demonstrated the effect of cultivar, but not of growing location, on the soy 
protein subunit composition and AC of alcalase hydrolysates. The study also suggested 
the possibility to modify the protein profiles of soybean through breeding programs to 
produce soy hydrolysates with improved AC. It was possible to select a specific soybean 
cultivar that exhibited high antioxidant capacity after alcalase hydrolysis, which can be 
further utilized as natural supplements or functional food ingredients 
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CHAPTER 6 
PEPSIN PANCREATIN HYDROLYSIS OF PROTEIN-BASED 
BEVERAGES AND INGREDIENTS ENHANCES THEIR ANTIOXIDANT 
CAPACITY AND INHIBITORY EFFECT ON STARCH DIGESTIVE ENZYMES 
 
6.1 Abstract 
Emerging health trends are driving towards the development and use of nutritional 
beverages as a dietary approach for antihyperglycemic management. Nine protein-based 
beverages and ten functional ingredients (I-5 to 14) were analyzed for their antioxidant 
capacity and starch-hydrolyzing enzymes inhibitory activity. The beverages include 
experimental products (SAI 1 to 4), commercial products (#1 and 2), cow’s milk, regular 
soymilk and soymilk prepared from low glycinin soybeans. The Oxygen Radical 
Absorbance Capacity (ORAC) values of these beverages ranged from 11.1 to 52.1 µmol 
Trolox Equivalents (TE)/mL sample. They showed no inhibition of α-amylase and α-
glucosidase activity, except for commercial 1, soymilk and low-glycinin soymilk which 
inhibited α-glucosidase by 9.8, 9.4 and 10.2%, respectively. Non-protein based 
ingredients 8 and 14 exhibited α-glucosidase inhibitory activity with IC50 of 16.7 and 
88.5 µg/mL, respectively and α-amylase inhibitory activity with IC50 of >2,500.0 and 
325.1 µg/mL, respectively. Four beverages and four protein-based ingredients were 
selected for in vitro digestion using pepsin and pancreatin. Upon enzymatic hydrolysis, 
the antioxidant capacity and α-glucosidase inhibitory activity increased significantly 
(p<0.05). Ingredient 9 hydrolysate showed the highest ORAC value with an increase 
from 504.7 to 983.8 µmol TE/g. SAI 3 hydrolysate (SAI 3H) and SAI 4 hydrolysate (SAI 
4H) had higher α-glucosidase inhibitory activity with 84.5 and 85.5%, respectively, than 
1.0 mM acarbose with 62.8% inhibition. SAI 3H and 4H had similar peptide mass profile 
and were composed of unique peptides with masses 649.19, 884.55, 1108.60, 1139.73, 
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1152.43 and 1267.91 m/z. This research highlights the importance of pepsin pancreatin 
hydrolysis of protein-based beverages and ingredients to enhance their antioxidant 
capacity and enzyme inhibitory activity for hyperglycemic management.  
6.2 Introduction 
Postprandial hyperglycemia is considered as the major determinant of the 
development of type 2 diabetes mellitus (T2DM). Hyperglycemia is characterized by 
elevated glucose concentration in blood caused by insulin resistance and, in some cases, 
combined with insulin deficiency (DeFronzo RA, 2004). The modulation of postprandial 
hyperglycemia is an essential treatment for the pathogenesis of T2DM and hence, it is 
important to understand the factors affecting the rise in blood glucose after a meal. The 
majority of glucose in blood is produced by hydrolysis of dietary carbohydrate by 
enzymes such as pancreatic α-amylase and intestinal α-glucosidase (Elsenhans and 
Caspary, 1987). The inhibition of these enzymes leads to a delay in carbohydrate 
digestion, prolonged digestion time and transport of undigested carbohydrates to lower 
intestinal parts. This ultimately reduces the rate of glucose absorption into the 
bloodstream (Hillebrand et al., 1979). Acarbose and miglitol are commercially available 
oral antihyperglycemic drugs which have been proven to inhibit α-amylase and α-
glucosidase activities (Kim et al., 1999; Asano, 2003; Bischoff, 1994). Although acarbose 
is a potent therapeutic approach for T2DM treatments, it causes side effects such as 
flatulence and diarrhea (Holman, 1999). Other anti-diabetic drugs, for example, 
metformin is associated with increased risk of lactic acidosis, whereas thiazolidinediones 
increases the risks of cardiovascular and bone-related health problems (Hamnvik and 
McMahon, 2009).  
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Bioactive compounds from traditional plants, fruits and vegetables have been used as 
new sources of antihyperglycemic agents that are natural and safe (Alarcon-Aguilara, 
1998; Grover et al., 2002; Bhandari et al., 2008). The phenolic compounds present in 
raspberries, apples and seaweed also demonstrated antihyperglycemic effect (Zhang et 
al., 2010; Adyanthaya et al., 2008; Apostolidis and Lee, 2010). Soybean is a major source 
of proteins and phytochemicals which are known to exert anti-diabetic potential (Kwon et 
al., 2010). Fermentation of soymilk using Lactobacillus bulgaricus and Lactobacillus 
acidophilus could be used to manage glucose homeostasis by increasing α-glucosidase 
and α-amylase inhibition. Apostolidis (2007) suggested that fermentation altered the 
structure and content of phenolic compounds and bioactive peptides which caused an 
increase in inhibitory effects on both enzymes. 
Brownlee (2005) found that hyperglycemia also increased the production of free 
radicals in mesangial cells, renal glomerulus, neuron cells in peripheral nerves and 
capillary endothelial cells in the retina. It is important to scavenge these free radicals to 
prevent oxidative stress and ultimately microvascular complications. Soy peptides 
derived from enzymatic hydrolysis and/or fermentation, have high oxidative inhibitory 
capacity due to their ability to scavenge free radicals (Elias et al., 2008). Chen et al. 
(1998) found that histidine-containing soy peptides could serve as metal-ion chelators, 
oxygen quenchers and hydroxyradical scavengers. 
Currently limited information is available on the effect of enzymatic hydrolysis and 
its derived peptides on the inhibition of starch digestive enzymes activities. This study 
aimed to evaluate the peroxyl radical scavenging antioxidant capacity as well as α-
glucosidase and α-amylase inhibitory activities of protein-based beverages and 
55 
 
ingredients, pre- and post-in vitro digestion using pepsin and pancreatin. We also 
examined the electrophoretic (SDS-PAGE) protein profiles and MALDI-TOF peptide 
mass profiles to identify unique peptides which could be used as potential therapeutic 
compounds to control postprandial hyperglycemia.  
6.3 Materials and Methods 
6.3.1 Materials 
6.3.1.1 Beverages and ingredients 
Four experimental protein-based beverages (SAI 1 to 4) and ten ingredients (I-5 to 
14) were kindly provided by SAI International (Geneva, IL). SAI 3 and 4 were dietary 
supplement with cinnamon flavor, fortified with organic soy. UHT cow’s milk (CM), 
regular soymilk (SM) and soymilk prepared from low glycinin soybeans, enriched with 
β-conglycinin (LGS) were provided by an on-going clinical trial at the University of 
Illinois at Urbana Champaign. Two commercially-available glucose-control beverages, 
Glucerna Shake by Abbott Laboratories (identified as C1) and Boost by Nestle 
HealthCare Nutrition (identified as C2), were obtained from a local pharmacy in Urbana, 
IL.  
6.3.1.2 Chemicals 
Pepsin (E.C. 3.4.23.1, 662 units/mg), pancreatin (8x USP, from porcine pancreas), α-
amylase (from porcine pancreas, E.C. 232.565.6, 21.6 units/mg), α-glucosidase (from 
bakers yeast, EC 232.604.7, 21 units/mg), acarbose (EC 260.030.7), p-nitrophenyl-α-d-
glucopyranoside, soluble starch, trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2 
carboxylic acid)  and bovine serum albumin were purchased from Sigma-Aldrich (St. 
Louis, MO). Fluorescein [3’,6’-dihydroxyspiro (isobenzofuran-1[3H],9’[9H]-xanthen)-
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3-one] was purchased from Fisher Scientific (Hanover Park, IL). AAPH [2,2’-azobis(2-
amidinopropane) dihydrochloride] was purchased from Aldrich (Milwaukee, WI). Mini-
Protean TGX 4-20% precast gel, Laemli buffer, 2-mercaptoethanol and precision plus 
protein standard for SDS-PAGE were purchase from Bio-Rad (Hercules, CA). All other 
chemicals, unless otherwise specified, were purchased from Sigma-Aldrich (St. Louis, 
MO).  
6.3.2 Sample preparation 
The tested ingredients were prepared according to their percent composition (w/v) 
provided by SAI International. Ingredients 5, 8-14 were dissolved in deionized water, 
whereas ingredients 6 and 7 were dissolved in DMSO and centrifuged (2000 rpm, 10 
min) before the supernatant was collected for analysis. The four glucose-control SAI 
beverages were prepared by mixing 2.5 g dry weight in 24 mL deionized water. All 
beverages were placed in beakers and stirred using multiple-core magnetic stir plate (RO 
10 Power IKAMAG, IKA Works, Inc, Wilmington, NC) at timed intervals, until 
homogenous.  These samples were then evaluated for DC soluble protein, ORAC, α-
amylase and α-glucosidase assays.  
6.3.3 Protein extraction  
Fifty mg of the protein-based sample was mixed with 1 mL of extracting buffer (0.05 
M Tris-HCL buffer, pH 8.2) and sonicated using Bransonic model 2510 (Bransonic 
Ultrasonic Corporation, Danbury, CT) for 70 min at 40 °C, with vortexing every 10 min 
to avoid settlement of the sample. Following extraction, the samples were centrifuged at 
20,000g for 30 min at 4 °C in an Eppendorf Centrifuge (model 5417R, Brinkmann 
Instruments, Westbury, NY), and the obtained supernatant was used for SDS PAGE.  
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6.3.4 Soluble protein measurement by Detergent Compatible (DC) protein 
quantification assay 
Soluble protein was quantified by the Detergent Compatible Protein Microplate 
Assay™ protein assay (Bio-Rad, Hercules, CA) based on the Lowry (Folin) assay as 
described by Dia et al. (2009). The procedure consists of adding 5 μL of samples or 
bovine serum albumin (BSA) for the construction of standard curve in the range 10–
1600 μg/mL. After which, 25 μL of reagent A was added and 200 μL of reagent B was 
added followed by 15 min incubation at 25 oC. The absorbance was read at 630 nm using 
a 96-well plate reader (Biotek Instruments, Winooski, VT). Total soluble protein 
concentration of the fractions from affinity chromatography and soybean products were 
quantified based on the BSA standard curve (y = 0.0002 x - 0.007, R2 = 0.99).  
6.3.5 Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis (SDS-PAGE) of 
protein-based ingredients and beverages.  
Proteins extracted from samples were mixed with sample loading buffer [950 μL 
Laemmli SDS buffer (Biorad, 161-0737) and 50 μL 2-mercaptoethanol] with a 1:1 ratio. 
A sample of 20 µg of total protein was run on a 10 lane 4-20% Tris-HCL Bio Rad Ready 
Gels. The gels were then fixed with 40% methanol and 10% acetic acid for 20 minutes. 
Next, they were stained with Colloidal Coomassie Blue G-250 overnight. They were 
destained in 10% acetic acid for 30 min, and imaged using the GS 800 Calibrated 
Densitometer (Bio-Rad Laboratories, Hercules, CA). Determination of the molecular 
weight of protein bands was confirmed by comparing theoretical molecular weights with 
experimental data.  
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6.3.6 Preparation of soy protein hydrolysates using in vitro simulated 
gastrointestinal digestion with pepsin and pancreatin 
Simulated digestion of protein-based beverages and ingredients were performed 
following Megias et al. (2004) with several modifications. Briefly, sample was suspended 
in water (1:20 w/v) and a sequential enzyme digestion was carried out with pepsin [E.C. 
3.4.23.1, 662 units/mg; enzyme/flour, 1:20 (w/w); pH 2.0] and pancreatin [8x USP, from 
porcine pancreas; enzyme/flour, 1:20 (w/w); pH 7.5] at 37 ºC for 1.5 h each. Pancreatin 
(8× USP, from porcine pancreas) converts not less than 200 times its weight of USP 
potato starch reference standard into soluble carbohydrates and not less than 200 times its 
weight of casein into peptides. Pancreatin hydrolyzes fats to glycerol and fatty acids, 
changes proteins into peptides and derived substances, and converts starch into dextrins 
and sugar. It contains lipase, not less than 16 USP units/mg; protease, not less than 200 
USP units/mg; and amylase, not less than 200 USP units/mg. The hydrolysis was stopped 
by heating at 75 °C for 20 min. The resulting hydrolysate was centrifuged at 27000g for 
15 min. The pH of the hydrolysates was adjusted to 7.0 before ultra-filtration using 3,000 
Da MWCO membrane (Millipore).  The hydrolysates were then lyophilized in a 
FreeZone freeze-dry system (Kansas City, MO). All samples were stored at -80 °C until 
analysis. 
6.3.7 Measurement of antioxidant capacity by the Oxygen Radical Absorbance 
Capacity (ORAC) assay  
The oxygen radical absorbance capacity assay (ORAC) was adapted from published 
methods (Prior et al., 2003; Davalos et al., 2004). Fluorescein and AAPH solutions were 
prepared using 75 mM phosphate buffer, pH 7.4.  In triplicate (20 µL), samples and 
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Trolox standard dissolved in 75 mM phosphate buffer at concentrations ranging from 4 
µM to 150 µM,  or 75 mM phosphate buffer blank were added to a 96-well black walled 
plate; after which, 120 µL Fluorescein was added and incubated for 15 min at 37˚C.  
After incubation 60 µL AAPH was added before reading immediately in a fluorescent 
FLx800tbi Synergy 2 multi-well plate reader, (BioTek, Winooski, VT), at 37˚C, 
sensitivity 60, read every 2 min for 120 min with excitation 485 and emission 528 
nm. Fluorescein reacted with the free radicals generated by AAPH to generate a non-
fluorescent product.  Loss of fluorescence was measured over time and the area under the 
curve (AUC) was calculated. The ORAC values for beverage products were expressed as 
µmol Trolox Equivalent (TE)/mL. To understand the role of each ingredient on 
antioxidant capacity, the ORAC values for ingredients were expressed as µM TE without 
adjusting per gram solids. To examine the effect of hydrolysis, the value for beverages 
and ingredients (pre- and post-enzymatic hydrolysis) were expressed as µmol TE/g. 
6.3.8 α-amylase inhibition assay 
The α-amylase inhibitory activity was determined using type VI-B porcine pancreatic 
α-amylase (Apostolidis et al., 2007). Briefly, a mixture of 500 μL of sample or acarbose 
solution (1.0 mM), and 500 μL of 0.02 M sodium phosphate buffer (pH 6.9 with 6 mM 
sodium chloride) containing α-amylase solution (10.8 U/mL) was incubated at 25 °C for 
10 min. After incubation, 500 μL of a 0.5% soluble starch solution in 0.02 M sodium 
phosphate buffer (pH 6.9 with 6 mM NaCl) was added to each tube at timed intervals. 
The reaction mixtures were then incubated at 25 °C for another 10 min followed by 
addition of 1.0 mL of dinitrosalicylic acid color reagent. The test tubes were then placed 
in a boiling water bath for 5 min to stop the reaction and cooled to room temperature. The 
60 
 
reaction mixture was then diluted with the addition of 10 mL of distilled water and 
absorbance was measured at 540 nm with a microplate reader, ELX 808 (Bio-Tek, 
Winooski, VT). The readings were compared with the controls, containing buffer in place 
of sample extract. The α-amylase inhibitory activity was expressed as % inhibition and 
was calculated as follows: 
 
 
6.3.9 α-glucosidase inhibition assay 
The α-glucosidase activity was measured, based on Apostolidis et al. (2007), using p-
nitrophenyl-α-d-glucopyranoside (pNPG) as the substrate, which was hydrolyzed by α-
glucosidase to release p-nitrophenol, a color agent that could be monitored at 405 nm. A 
mixture of 50 μL sample or acarbose solution (1.0 mM), and 100 μL 0.1 M phosphate 
buffer (pH 6.9) containing α-glucosidase solution (1.0 U/mL) were incubated in 96 well 
plates at 25 °C for 10 min. After pre-incubation, 50 μL of 5 mM pNPG solution in 0.1 M 
phosphate buffer (pH 6.8) was added to each well at timed intervals. The reaction was 
performed at 25 °C for 5 min. Before and after incubation, the release of p-nitrophenol 
from pNPG was monitored at 405 nm every minute for 5 min by a microplate reader, ELX 
808 (Bio-Tek, Winooski, VT). The α-glucosidase activity was determined by comparing 
with that of control which had 50 μL of buffer solution in place of the sample. The α-
glucosidase inhibitory activity was expressed as % inhibition and was calculated as 
follows: 
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6.3.10 Peptide mass mapping by Matrix-Assisted Laser Desorption Ionization Time-
of-Flight (MALDI-TOF) 
Pepsin pancreatin hydrolysates were analyzed by MALDI-TOF using an Applied 
Biosystems Voyager-DE STR (Foster City, CA, USA) for molecular mass peptide 
mapping. The following parameters were used in the analysis: linear mode of operation, 
positive polarity and 500-20,000 m/z scanning range. 
 
6.3.11 Experimental design 
 
 
Figure 15. Experimental design to measure the antioxidant capacity and 
antihyperglycemic activity of selected beverages and ingredients. 
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6.3.12 Statistical analysis 
The statistical analyses were performed using Statistical Analysis System version 9.1 
(SAS Institute, Cary, NC).  Data were analyzed using Analysis of Variance. Means were 
generated and adjusted with Least Significant Difference test. Means were considered to 
be significantly different at p values < 0.05. The concentration to inhibit 50% of the 
target enzymes (IC50) was determined by non-linear regression (curve fit) using 
GraphPad Prism Software. All experiments were performed at least twice and analysis 
for each experiment was carried out in triplicates. 
 
6.4 Results and discussion 
6.4.1 Protein content and antioxidant capacity of selected beverages and ingredients  
Proteins have been widely recognized as natural antioxidants that possess multiple 
health functionality (Elias, 2008). In this study, nine beverages were evaluated for their 
soluble protein content (Figure 16). Soluble protein content of these beverages ranged 
between 25.5 and 77.7 mg/mL. Sample C2 had the highest soluble protein content 
followed by C1 with 70.1 mg/mL. SAI 1 to 4 beverages, prepared according to 
manufacturer’s recommendation (2.5 grams in 24 mL water), corresponded to soluble 
protein content of 35.0, 46.6, 46.4 and 25.5 mg/mL, respectively.  CM, SM and LGS had 
soluble protein content of 37.5, 37.4 and 44.2 mg/mL, respectively. These results are in 
accordance to the stated amount of protein per serving listed by the manufacturers.  
 
 
 
63 
 
0
20
40
60
80
100
Pr
ot
ei
n 
Co
nc
en
tr
at
io
n 
(m
g/
m
L)
Beverages
 
Figure 16. Soluble protein concentration of SAI beverages in comparison to other 
beverages. Protein content was expressed in mg soluble protein per mL sample (mg/mL). 
Each value is expressed as mean ± SD in triplicate experiments. Means followed by 
different letter(s) are statistically different from each other (p < 0.05).  
 
Peroxyl radicals played a major role in exerting damage to cellular macromolecules 
such as DNA. Halliwell (1995) reported that oxidative damage was mainly caused by 
peroxyl radicals with long half-lives and great affinity to biological fluids. The Oxygen 
Radical Absorbance Capacity (ORAC) values of the beverages ranged from 11.1 to 52.1 
µmol TE/mL (Figure 17). These values were higher than previously reported for human 
milk (3.4 ± 0.5 µmol TE/mL) of lactating mothers in Vancouver, Canada (Tijerina Saenz 
et al., 2009). It was evident that C2 exhibited the highest ORAC value, followed by C1. 
Such high ORAC values could be attributed to the functional ingredients that were 
present in these samples such as vitamin A palmitate, ascorbic acid and vitamin E acetate. 
For every serving, C2 contained 10% vitamin A, 170% vitamin C and 200% vitamin E, 
whereas C1 had 25% vitamin A, 100% vitamin C and 25% vitamin E. These represented 
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the percent daily values which were based on a 2,000 calorie diet. SAI 1 had the 
significantly highest ORAC value in comparison to the other three SAI beverages. SAI 1 
posed a significant difference in ORAC value when compared to the three milk samples. 
Figure 18 (A) showed the role of ten ingredients (I-5 to I-14) in scavenging peroxyl 
radicals as measured by their ORAC values, in comparison to SAI 1. I-11 exhibited the 
highest antioxidant capacity with an ORAC value of 7,974.5 ± 448.7 μM TE. This was 
followed by I-5 and I-12 with ORAC values of 4,609.2 ± 276.6 and 4,811.0 ± 263.5 μM 
TE, respectively. The ingredients were prepared according to their percent composition 
(w/v) in the formula as recommended by SAI International. Figure 18 (B) depicted the 
actual ORAC values of each ingredient adjusted with the amount used in the experiment. 
I-14 had the highest peroxyl radical scavenging antioxidant capacity, followed by I-5.  
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Figure 17. Oxygen Radical Absorbance Capacity (ORAC) of SAI beverages in 
comparison to other beverages. ORAC value was expressed in µmol Trolox equivalents 
per mL of sample (µmol TE/mL). Each value is expressed as mean ± SD in triplicate 
experiments. Means followed by different letter(s) are statistically different from each 
other (p < 0.05).  
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(B) 
 
Figure 18. Oxygen Radical Absorbance Capacity (ORAC) of SAI ingredients in 
comparison to SAI 1 expressed in µM Trolox equivalents (µM TE) (A), and ORAC 
values of ingredients expressed in µmol TE/g (B). The ingredients were prepared 
according to their percent composition (w/v) in the formula as recommended by SAI 
International. Each value is expressed as mean ± SD in triplicate experiments. Means 
followed by different letter(s) are statistically different from each other (p < 0.05).  
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6.4.2 Antihyperglycemic effect of selected beverages and ingredients 
Psaltopoulou et al. (2010) evaluated the association of glycemic indices with total 
dietary antioxidant capacity in healthy adults and concluded that higher consumption of 
antioxidants should be implemented in public health strategies, in order to better control 
glycemic markers, and prevent the development of diabetes. After measuring the peroxyl 
radical scavenging activity of these beverages and ingredients, the antihyperglycemic 
effect was also evaluated by measuring the inhibition of starch-metabolizing enzymes 
specifically α-glucosidase and α-amylase. 
All beverages had no α-glucosidase inhibitory activity, except C1, SM and LGS with 
9.8, 9.4 and 10.2% inhibition, respectively (data not shown). These beverages were 
opaque and we performed a 1:10 dilution before measuring the α-glucosidase inhibitory 
activity. This is in agreement with a previously published study which measured the α-
glucosidase inhibitory activity of soymilk with 10x dilution to be approximately 8% 
(Apostolidis et al., 2007).  
As shown in Figure 19, I-8 and I-14 inhibited α-glucosidase activity with IC50 of 16.7 
and 88.5 µg/mL, respectively. I-8 had similar α-glucosidase inhibitory activity as 
raspberry extracts (IC50 ranging from 16.8 to 34.3 µg/mL) (Zhang et al., 2010). IC50 value 
corresponds to the concentration of the ingredient that resulted in 50% inhibition of α-
glucosidase activity. Therefore, a lower IC50 value refers to a higher α-glucosidase 
inhibitory activity. When prepared according to the recommended SAI formula, I-8 and I-
14 inhibited α-glucosidase by 99.9 and 93.6%, respectively.  
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Figure 19. Effect of non-protein based ingredients 8 (A) and 14 (B) on inhibitory activity 
of α-glucosidase. IC50 value corresponds to the concentration of the ingredient that 
resulted in 50% inhibition of α-glucosidase activity. Inhibition effect was determined 
using pNPG as a substrate. Each value is expressed as mean ± SD in triplicate 
experiments.  
 
IC50 = 88.5 µg/mL 
IC50 = 16.7 µg/mL 
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All beverages showed no observed α-amylase inhibitory activity. This was not 
consistent with a previous study which demonstrated α-amylase inhibitory activity of 
milk and soymilk samples (Apostolidis et al., 2007). Alternatively, our positive control, 
1.0 mM acarbose, showed 44.1% α-amylase inhibition and this was in accordance with 
other published study which reported the IC50 of acarbose against α-amylase to be 1.1 
mM (Heo et al., 2009).  
As reported in Figure 20, α-amylase inhibitory activity was also observed in I-8 and I-
14 with IC50 of >2,500 and 325.1 µg/mL, respectively. The α-amylase inhibitory activity 
of I-14 was similar to acetone extract of Spatoglossum schroederi (Brazilian brown 
seaweed) which had IC50 of 580 µg/mL (Teixeira et al., 2007). When prepared according 
to the recommended SAI formula, I-8 and I-14 inhibited α-glucosidase by 31.9 and 
44.6%, respectively.  
 It was interesting that I-8 was more potent in inhibiting α- glucosidase activity than I-
14, although I-8 had lower α- amylase inhibitory activity than I-14. This demonstrated the 
possibility that I-8 had a specific α- glucosidase inhibitory mechanism. Zhang et al. 
(2010) also suggested that raspberry (Rubus idaeus L.) extracts had specific mechanism 
to inhibit α-glucosidase. Overall, these results indicated that I-8 and I-14 had strong α- 
glucosidase and mild α- amylase inhibitory activity. This was actually desirable since 
excess inhibition of α-amylase caused unhydrolyzed carbohydrates to be fermented by 
the gut bacteria, leading to the development of flatulence and diarrhea (Bischoff, 1994; 
Horii, 1987).  
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Figure 20. Effect of non-protein based ingredients 8 (A) and 14 (B) on inhibitory activity 
of α-amylase. IC50 value corresponds to the concentration of the ingredient that resulted 
in 50% inhibition of α-amylase activity. Inhibition effect was determined using starch as 
a substrate. Each value is expressed as mean ± SD in triplicate experiments.  
 
IC50 = 325.1 µg/mL 
IC50 > 2500.0 µg/mL 
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6.4.3 Antioxidant capacity and antihyperglycemic effect of pepsin pancreatin 
hydrolysates 
Bioactive peptides, produced from fermentation or in vivo digestion of proteins, exert 
strong free radical scavenging activity (Chen et al., 1998). Four SAI beverages were 
chosen to undergo in vitro simulated digestion using pepsin pancreatin. Since these 
proteases are secreted in human stomach and small intestine during food digestion, the 
peptides generated from these beverages are similar to those produced during digestion in 
a human body (Megias et al., 2008). As shown in Figure 21, it was evident that all four 
SAI beverages (SAI 1H, 2H, 3H and 4H) experienced a significant increase in ORAC 
values after pepsin pancreatin hydrolysis (p<0.05). The ORAC values of SAI 1H, 3H and 
4H increased from 227.3, 164.7, 114.1 to 696.0, 698.7, 588.3 µmol TE/g, respectively. 
SAI 2H had the lowest ORAC value (489.6 ± 45.2 µmol TE/g) compared to the other 
three SAI hydrolysates.  
Four protein-based SAI ingredients (I-9H, 10H, 11H and 12H) were also hydrolyzed 
using pepsin pancreatin. Based on Figure 21, the antioxidant capacity of all four 
ingredients increased significantly after pepsin pancreatin hydrolysis (p < 0.05). I-9H had 
the highest ORAC value of 983.8 µmol TE/g and was followed by I-12H and I10H with 
894.5 and 853.0 µmol TE/g, respectively. Although I-11H increased more than two-fold 
from 144.4 to 553.1 µmol TE/g after hydrolysis, it still had the lowest antioxidant 
capacity compared to the other three ingredients.  
These findings demonstrated the enhanced ability of proteins to scavenge free 
radicals after in vitro simulation of human gastrointestinal digestion. Such a positive 
increase in ORAC values for the SAI beverages and their constitutional ingredients could 
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be attributed to the presence of bioactive peptides that were produced upon the 
breakdown of proteins during pepsin pancreatin hydrolysis. This finding is in agreement 
with previous studies in which soy derived bioactive peptides with specific sequence 
exerted strong antioxidant capacity upon protease digestion (Chen et al., 1998; Saito et 
al., 2003).   
 
 
Figure 21. Oxygen Radical Absorbance Capacity (ORAC) of SAI beverages, protein-
based ingredients and their hydrolysates. The enzymes used for simulated protein 
digestion were pepsin from porcine gastric mucosa and pancreatin from porcine pancreas. 
Each hydrolysate was tested in triplicate with ORAC values expressed in µmol Trolox 
equivalents per gram of sample (µmol TE/g). Means followed by different capital letters 
indicates statistical difference among hydrolyzed samples; means followed by different 
small letters indicates statistical difference among non-hydrolyzed samples; means 
followed by * indicates statistical difference between each hydrolyzed and non-
hydrolyzed samples (p < 0.05).  
 
In addition to their high antioxidant capacity, fermented protein-based beverages 
such as yogurt, milk and soymilk have the potential to reduce postprandial hyperglycemia 
by inhibiting the activity of α-glucosidase and α-amylase (Apostolidis et al., 2006; 
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Apostolidis et al., 2007). Our results indicated that upon enzymatic hydrolysis of SAI 
beverages and ingredients, α-glucosidase inhibitory activity increased significantly. We 
did not observe any α-glucosidase inhibition prior to hydrolysis of these samples. Figure 
22 showed SAI 3H and 4H had the highest inhibitory activity with 82.9% and 84.0%, 
respectively. This inhibition was found to be higher than acarbose, an antihyperglycemic 
drug, at a concentration of 1.0 mM. SAI 2H showed the lowest inhibition of α-
glucosidase (17.1%) among the SAI beverages. Pepsin pancreatin hydrolysates of 
ingredients did not have significant α-glucosidase inhibition, as compared to hydrolysates 
of beverages. Hence, consuming these ingredients together as a beverage would better 
inhibit α-glucosidase activity, instead of consuming them independently. On the other 
hand, all hydrolysates did not show any α-amylase inhibitory activity. This suggested the 
possibility that these protein hydrolysates specifically targeted α-glucosidase. All these 
demonstrate the potency of SAI hydrolysates, especially SAI 3H and 4H, as α-
glucosidase inhibitors which provide a practical approach to manage hyperglycemic 
patients.  
We also carried out pepsin pancreatin hydrolysis without the presence of substrates 
(protein-based beverages and ingredients) to examine the potential inhibition of pepsin 
and pancreatin on α-glucosidase. The results showed that pepsin pancreatin alone did not 
inhibit any α-glucosidase activity. 
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Figure 22. Inhibitory activity of protein hydrolysates on α-glucosidase. Inhibitory effect 
was determined using pNPG as a substrate and acarbose (1.0 mM) as a positive control. 
Each value is expressed as mean ± SD in triplicate experiments. Means followed by 
different letter(s) are statistically different from each other (p < 0.05).  
 
 
6.4.4 Characterization of SAI beverages and protein-based ingredients before and 
after pepsin pancreatin hydrolysis 
It is important to further characterize the bioactive proteins or peptides present in 
these hydrolysates. Protein extracts of SAI 1 to 4 and ingredients 9 to 12 showed different 
electrophoretic (SDS-PAGE) profiles as shown in Figure 23(A). SAI 1, 3 and 4 showed 
similar protein profiles with distinct bands ranging from 25 to 30 kDa. It was apparent 
that SAI 2 had different protein profiles compared to the other SAI beverages with 
highest intensity of low molecular weight proteins between 12 and 15 kDa. SAI 2 also 
demonstrated intense bands at 20, 25, 50 and 65 kDa. SDS PAGE profiles of ingredient 9 
showed intense bands lower than 10 kDa indicating its possibility as hydrolyzed peptides. 
Ingredients 10 showed strong bands lower than 10 kDa although some bands could be 
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observed at 25 and 65 kDa comparable to those of SAI 2. Ingredient 11 also showed 
intense band at 30, 65 and 67 kDa, with a similar band as SAI 1 at 67 kDa. Ingredient 12 
had strong bands ranging from 25 to 30 kDa with similar protein profiles observed for 
SAI 1, 3 and 4. Figure 23(B) depicted the SDS PAGE electrophoretic profiles of C1, C2, 
SM, LGS and CM. We observed a similarity in protein profiles of C2 and CM. Sample 
LGS had major protein bands ranging from 45 to 67 kDa corresponding to β-conlycinin 
subunits (α, α’ and β). 
 
(A)                                                                   (B) 
 
Figure 23. SDS PAGE profile of extracted proteins from SAI beverages and protein-
based ingredients (A), as well as commercial beverages and milk samples (B). Each 
sample was run on a 4-20% gel, stained with Coomasie blue. Abbreviations: 
I:Ingredient; C1:Commercial product #1; C2:Commercial product #2; SM:Soymilk; 
LGS:Low-glycinin soymilk; CM: UHT cow’s milk. 
 
Figure 24 showed the MALDI-TOF-MS peptide mass profiles after enzymatic 
hydrolysis of SAI beverages with pepsin pancreatin. It was clear that SAI 2H have a 
different profile compared to the other SAI beverages. SAI 2H showed distinct signals at 
929.91, 1125.57, 1141.77, 1345.91 and 1361.98 m/z. SAI 1H, 3H and 4H showed major 
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signals at 556.08 and 863.32 m/z. SAI 1H also had some similarities with SAI 3H 
characterized by intense peaks at 775.25 and 997.60 m/z.  SAI 3H and 4H exhibited very 
similar profiles with common ions including 649.19, 884.55, 1108.60, 1139.73, 1152.43 
and 1267.91 m/z.  
Figure 25 showed a list of peptide masses determined by MALDI-TOF-MS of protein 
hydrolysates from pepsin pancreatin hydrolysis of protein-based SAI ingredients. I-9H 
had strong signals at 1253.99 and 1276.32 m/z corresponding to SAI 1H; 775.44 and 
997.87 m/z corresponding to SAI 1H and 3H; 1125.91 m/z corresponding to all SAI 
hydrolysates. I-11H was characterized by intense peaks at 976.42 m/z corresponding to 
SAI1H; 775.25 m/z corresponding to SAI 1H and 3H; 1108.68 m/z corresponding to SAI 
3H and 4H; 863.41 m/z corresponding to SAI 1H, 3H and 4H. I-12H showed high signals 
at 1307.79 m/z corresponding to SAI 1H and 1345.87 m/z corresponding to SAI 1H and 
2H. Further purification and identification of these peptides are needed to study their 
antioxidant capacity and α-glucosidase inhibitory activity potential. 
This study investigated the potential of peroxyl radical scavenging antioxidant 
capacity and antihyperglycemic property of protein-based beverages and their selected 
ingredients. Our study is the first to assess the effect of in vitro simulated digestion of 
these beverages and ingredients using pepsin pancreatin. The results indicated that 
antioxidant capacity and α-glucosidase inhibitory activity increased significantly after 
pepsin pancreatin hydrolysis. In conclusion, this study highlights the potential of these 
beverages as a part of dietary approach to control postprandial hyperglycemia in type 2 
diabetic patients.  
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(A)                                                                                      (B) 
 
 
 
 
(C)                                                                                             (D) 
 
Figure 24. MALDI-TOF spectrum of pepsin pancreatin hydrolysates of SAI 1 (A), SAI 2 (B), SAI 3 (C) and SAI 4 (D). The 
following paramaters were used: linear mode of operation, positive polarity and 500-20,000 Da scanning range.
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(A)         (B)  
 
 
 
(C)            (D) 
 
 
Figure 25. MALDI-TOF spectrum of pepsin pancreatin hydrolysates of ingredient 9 (A), Ingredient 10 (B), Ingredient 11 (C) and 
Ingredient 12 (D). The following parameters were used: linear mode of operation, positive polarity and 500-20,000 Da scanning range.
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CHAPTER 7 
SUMMARY AND INTEGRATION 
 
The overall objective of this research was to evaluate the antioxidant capacity and 
antihyperglycemic properties of soy protein hydrolysates in vitro. Soy proteins have long 
been considered as a dietary source of natural antioxidants with important biological 
activities. One of the major storage proteins present in soy is β-conglycinin and 
researchers have reported the antioxidant potential of bioactive peptides derived from β-
conglycinin. However, limited research has been done to study the effect of different soy 
cultivars and growing location on the production of antioxidative peptides.  
In aim 1 of this research, we evaluated the antioxidant capacity of alcalase 
hydrolysates and soy protein profiles of nine improved soybean cultivars grown in three 
different locations in the Midwestern United States. The results showed that cultivars 1 
and 6 from all locations exhibited significantly lower total β-conglycinin and higher total 
glycinin than the other seven soybean cultivars. Cultivars 1 and 6 had the lowest content 
in α and α' subunit of β-conglycinin. Cultivar 6 had the highest content in A1,2,4 subunit 
of glycinin, whereas basic glycinin content was highest in cultivars 1 and 6. This 
demonstrated that protein profiles were significantly different among soy cultivars.  
It was also revealed in aim 1 that soy bioactive peptides showed strong peroxyl 
radical scavenging antioxidant capacity. Soy protein hydrolysates showed a significant 
difference in antioxidant capacity among different cultivars. Alcalase hydrolysate of 
cultivar 3 from Bloomington showed the highest antioxidant capacity, followed by 
hydrolysates of cultivar 8 from Huxley, 3 from Huxley and 3 from Findlay. It was also 
interesting to observe that the antioxidant capacity of soy protein hydrolysates was 
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similar to purified β-conglycinin hydrolysates, but not to purified glycinin hydrolysate. 
This supported previous study which concluded that β-conglycinin was more susceptible 
to protease hydrolysis, increasing the production of bioactive peptides, in comparison to 
glycinin. The MALDI-TOF-MS profile of cultivar 3 with the highest antioxidant capacity 
showed a distinct signal (100%) at m/z 3385, a peptide fragment from β-conglycinin. 
However, the profile of cultivar 9 with the lowest antioxidant capacity showed lower 
intensity (40%) at 3385 m/z. Further isolation of this peptide and identification of its 
amino acid sequence will be necessary to explore its potential antioxidant mechanism. 
Aim 1 established that the protein profiles of soybean, as raw materials, played a 
vital role in the antioxidant potential of their hydrolysates. The next challenge was to 
understand the effect of in vitro simulated gastrointestinal digestion of protein-based 
products on antioxidant capacity and antihyperglycemic management. Aim 2 addressed 
this problem and hypothesized that in vitro digestion with pepsin pancreatin will increase 
the antioxidant capacity, as well as starch-digestive enzymes inhibitory activity of 
protein-based beverages and ingredients.  
Our results indicated that upon enzymatic hydrolysis of SAI beverages and 
ingredients, antioxidant capacity and α-glucosidase inhibitory activity increased 
significantly. This was interesting since we did not observe any α-glucosidase inhibition 
prior to hydrolysis of samples. SAI 3H and 4H had higher α-glucosidase inhibitory 
activity than acarbose, an antihyperglycemic drug, at a concentration of 1.0 mM. The 
electrophoretic SDS-PAGE and MALDI-TOF peptide mass profiles of the hydrolysates 
displayed close similarity between samples 3H and 4H. Sample 2H had completely 
different pattern which possibly explained its lowest inhibitory activity on α-glucosidase 
80 
 
when compared to the other beverages. In addition, pepsin pancreatin hydrolysates of 
beverages showed significantly higher α-glucosidase inhibition, compared to 
hydrolysates of ingredients. Hence, consuming these ingredients together as a beverage 
would better manage postprandial hyperglycemia, instead of consuming them 
independently in the form of supplements. 
 This research suggests the possibility to modify the protein profiles of soybean 
through breeding programs to produce hydrolysates with improved antioxidant capacity. 
Protease digestion of soy protein enhanced the antioxidant efficacy due to production of 
antioxidant peptides. Our study is the first to assess the effect of in vitro simulated 
digestion of protein-based beverages and ingredients on antioxidant capacity and 
antihyperglycemic property. Our results indicated that antioxidant capacity and α-
glucosidase inhibitory activity increased significantly after pepsin pancreatin hydrolysis. 
In conclusion, this study highlights the potential of protein-based products as a part of 
dietary approach to increase antioxidant capacity and control postprandial hyperglycemia 
in type 2 diabetic patients.  
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CHAPTER 8 
CONCLUSIONS 
 
 
• The amount of protein, fat and moisture in nine soy cultivars used in this study 
ranged from 36.4% - 42.2%, 17.8% - 23.6%, 6.4% - 8.8%, respectively. 
• The total β-conglycinin and glycinin content of all soybean cultivars ranged from 
25.9 to 56.9% and 0.7 to 42.8%, respectively. 
• Cultivars 1 and 6 grown in three locations exhibited the highest total glycinin among 
the nine soybean cultivars. Cultivars 1F and 6F showed intense bands on A1,2,4 
chain and basic chain of glycinin, whereas the rest of the cultivars had more intense 
bands on α chain and α’ chain of β-conglycinin.  
• All soy protein hydrolysates showed notable antioxidant capacity which ranged from 
57.0 ± 2.9 to 81.1 ± 0.5 µmol TE/g flour.  
• The average antioxidant capacity for soybean, purified BC and purified GL 
hydrolysates were 36.2 ± 5.2, 31.8 ± 0.5 and 28.5 ± 0.2 µM Trolox equivalents/µg 
soluble protein, respectively. 
• The hydrolysates from cultivar 3B showed the highest AC (81.1 µmol TE/g flour), 
followed by the cultivar 8H, 3H and 3F (75.0, 74.5 and 74.3 µmol TE/g flour, 
respectively). 
• The current study showed significant effect of cultivars (p < 0.05) on the antioxidant 
capacity of alcalase hydrolysates and protein profiles of soybean. 
• Growing locations did not affect both the protein profiles of the soybean and  
antioxidant capacity of their alcalase hydrolysates (p>0.05). 
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• Protein content of beverages used in the second part of the study ranged between 
25.5 ± 1.4 and 77.7 ± 1.8 mg/mL. 
• The Oxygen Radical Absorbance Capacity (ORAC) values of the beverages ranged 
from 11.1 ± 0.0 to 52.1 ± 2.8 µmol TE/mL 
• Out of the ten ingredients tested, I-11 exhibited the highest scavenging peroxyl 
radicals as measured by their ORAC values of 7,974.5 ± 448.7 μM TE. 
• Ingredients 8 and 14 inhibited α-glucosidase activity with IC50 of 16.7 and 88.5 
µg/mL, respectively, whereas α-amylase inhibitory activity was also observed with 
IC50 of >2,500 and 325.1 µg/mL, respectively 
• All beverages and other ingredients had no α-glucosidase inhibitory activity, except 
C1, SM and LGS with 9.8, 9.4 and 10.2% inhibition, respectively but all of them did 
not inhibit α-amylase activity. 
• After simulated gastrointestinal digestion, the antioxidant capacity of protein based 
beverages and ingredients improved significantly. The ORAC values of SAI 1H, 2H, 
3H and 4H increased significantly from 227.3, 119.5, 164.7, 114.1 to 696.0, 489.6, 
698.7, 588.3 µmol TE/g, respectively.  
• Upon in vitro gastrointestinal digestion, SAI 3H and 4H had the highest α-
glucosidase inhibitory activity with 82.9% and 84.0%, in comparison to the other 
SAI hydrolysates and 1.0 mM acarbose. 
• SAI 1, 3 and 4 exhibited similar electrophoretic SDS PAGE protein profiles and 
MALDI-TOF-MS peptide mass profiles. 
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CHAPTER 9 
FUTURE STUDIES 
 
 
• Utilization of other antioxidant measurement assays such as tolox-equivalent anti-
oxidative capacity (TEAC), ferric reducing antioxidant power (FRAP) and 2,2-
diphenyl-1-picrylhydrazyl (DPPH) scavenging activity to study possible 
correlations. 
• Fractionation of protein hydrolysates using size exclusion chromatoghraphy is 
necessary to select a fraction with the highest antioxidant capacity. Further 
characterization by amino acid analysis using RP-HPLC and peptide sequencing 
by LC-MS-MS is also required to identify specific peptides with antioxidant 
capacity. 
• In vivo studies are essential to determine any relation of soy consumption and 
antioxidant capacity in the serum. The results will benefit patients suffering from 
antioxidant-related chronic diseases. 
• The binding modes of α-glucosidase and α-amylase inhibitors at the active site 
have to be investigated to obtain structural insight into the inhibitory mechanisms, 
in comparison to known a inhibitor, acarbose. 
• Sensory evaluation of protein hydrolysates should be conducted to determine 
product acceptability in commercial applications.  
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Appendix A 
 
 
 
Figure A.1 Bovine serum albumin standard curve for protein quantification 
 
 
 
 
Figure A.2 Trolox standard curve to determine antioxidant capacity in terms of µM 
Trolox Equivalent. 
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Figure B.1 Total glycinin (%) of cultivars 1 and 6 are statistically different than the other 
cultivars. Each value is expressed as mean ± SD in triplicate experiments. Means 
followed by star(s) are statistically different from each other (p < 0.05).  
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Figure B.2 Total β-conglycinin (%) of cultivars 1 and 6 are statistically different than the 
other cultivars. Each value is expressed as mean ± SD in triplicate experiments. Means 
followed by star(s) are statistically different from each other (p < 0.05).  
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Figure C.1 Antioxidant capacity of alcalase hydrolysates of low-glycinin cultivars (2, 3, 
5, 7, 8, 9 and 10), high-glycinin cultivars (1 and 6), purified β-conglycinin and purified 
glycinin against peroxyl radicals. Each value is expressed as mean ± SD in triplicate 
experiments. Means followed by different letter(s) are statistically different from each 
other (p < 0.05).  
 
 
 
 
 
 
Figure C.2 MALDI-TOF spectrum of alcalase hydrolysates of purified β-conglycinin (A) 
and purified glycinin (B) using the following parameters: linear mode of operation, 
positive polarity and 500-20,000 Da scanning range. 
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Appendix D 
 
(A) 
 
(B) 
 
(C) 
 
MALDI-TOF spectrum of alcalase hydrolysates of cultivars 1F (A), 2F (B) and 3F (C) 
using the following parameters: linear mode of operation, positive polarity and 500-
20,000 Da scanning range. 
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Appendix E 
(A) 
 
(B) 
 
(C) 
 
MALDI-TOF spectrum of alcalase hydrolysates of cultivars 5F (A), 6F (B) and 7F (C) 
using the following parameters: linear mode of operation, positive polarity and 500-
20,000 Da scanning range. 
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Appendix F 
(A) 
 
(B) 
 
(C) 
 
MALDI-TOF spectrum of alcalase hydrolysates of cultivars 8F (A), 9F (B) and 10F (C) 
using the following parameters: linear mode of operation, positive polarity and 500-
20,000 Da scanning range. 
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Appendix G 
 
Table G.1 Effect of cultivar and location on antioxidant capacity of extracted soy protein 
and soy hydrolysates. 
 
Cultivar Locationa Soy flour  Alcalase         Pepsin Pancreatin 
1  F  22.2 ± 0.9  32.5 ± 1.1  29.6 ± 3.8 
H  16.4 ± 0.6  34.3 ± 1.1   22.8 ± 0.1 
B  21.4 ± 1.3  27.7 ± 1.8  28.3 ± 0.3 
2  F  21.9 ± 1.5  37.4 ± 0.5  36.8 ± 1.1  
 H  21.9 ± 0.4  35.8 ± 1.7  27.8 ± 1.7 
 B  30.7 ± 0.4  34.7 ± 2.9  30.4 ± 0.7 
3  F  20.6 ± 0.8  38.3 ± 5.7  33.9 ± 2.5 
H  19.8 ± 0.8  47.3 ± 6.0  34.5 ± 0.3 
B  23.9 ± 0.8  41.9 ± 6.8  33.3 ± 1.2 
5  F  25.1 ± 0.7  33.0 ± 1.9  27.2 ± 0.3 
 H  17.8 ± 0.6  33.8 ± 2.2  29.5 ± 2.1 
 B  23.2  ± 0.9  35.5 ± 3.8  29.5 ± 0.3 
6  F  21.6 ± 0.4  36.1 ± 0.3  27.4 ± 0.5 
 H  22.5 ± 0.6  38.1 ± 2.1  35.9 ± 1.0 
 B  26.8 ± 1.5  30.1 ± 2.6  24.3 ± 1.1 
7  F  23.6 ± 0.2  37.1 ± 3.2  26.6 ± 0.7 
 H  15.8 ± 0.6  37.2 ± 2.6  31.4 ± 0.8 
 B  20.2 ± 0.7  31.6 ± 2.4  31.2 ± 0.8 
8  F  24.1 ± 0.8  38.0 ± 2.0  28.8 ± 0.3 
 H  26.2 ±0.8  40.6 ± 3.2  30.7 ± 3.9 
 B  27.8 ± 0.6  29.7 ± 3.8  32.1 ± 0.3 
9  F  22.4 ± 0.2  38.8 ± 4.7  24.8 ± 1.3  
 H  20.7 ± 1.3  32.2 ± 1.6  17.6 ± 0.9 
 B  19.0 ± 1.2  35.4 ± 5.4  29.8 ± 0.7 
10  F  29.6 ± 1.2  42.7 ± 4.1  26.3 ± 0.9 
 H  17.5 ± 0.7  43.5 ± 1.7  26.0 ± 3.6 
 B  18.8 ± 0.9  35.3 ± 5.5  29.6 ± 0.4 
a B=Bloomington; F=Findlay; H=Huxley 
b Values mean ± standard deviation (SD), expressed in μM TE/μg soluble protein 
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Appendix H 
 
Table H.1 Antioxidant capacity of 9 soybean cultivars grown in 3 different locations after 
two types of enzymatic hydrolysis using alcalase and sequential pepsin pancreatin. 
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Appendix I 
 
Table I.1 Effect of cultivar and location on antioxidant capacity of alcalase and pepsin 
pancreatin hydrolysates (μM TE/μg soluble protein) 
 
Cultivar   Locationa   Mean ± SDb 
1   F    31.0 ± 3.0cdefgh 
H    28.5 ± 6.4fghi 
B    28.0 ± 1.2ghi 
2   F    37.1 ± 0.9abc 
 H    31.8 ± 4.7bcdefgh 
 B    32.6 ± 3.0bcdefgh 
3   F    36.1 ± 4.6abcde 
H    40.9 ± 8.0a 
B    37.6 ± 6.4ab 
5   F    30.1 ± 3.4efghi 
  H    31.6 ± 3.0bcdefgh 
  B    32.5 ± 4.0bcdefgh 
6   F    31.7 ± 4.7bcdefgh 
  H    37.0 ± 1.9abcd 
  B    27.2 ± 3.7hi 
7   F    31.8 ± 6.1bcdefgh 
  H    34.3 ± 3.6bcdef 
  B    31.4 ± 1.6cdefgh 
8   F    33.4 ± 5.2bcdefg 
  H    35.7 ± 6.3abcde 
  B    30.9 ± 2.7defghi 
9   F    31.8 ± 8.2bcdefgh 
  H    24.9 ± 8.1i 
  B    32.6 ± 4.6bcdefgh 
10   F    34.5 ± 9.4bcdef 
  H    34.8 ± 9.9abcde 
  B    32.4 ± 4.7bcdefgh 
a B=Bloomington; F=Findlay; H=Huxley 
b Values mean ± standard deviation (SD), followed by the same letter(s) are not 
significantly different from each other (P > 0.05); n = 27 
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Appendix J 
 
Table J.1 Effect of cultivar and enzymatic processing on antioxidant capacity of alcalase 
and pepsin pancreatin hydrolysates (μM TE/μg soluble protein) 
 
Cultivar  Processinga     Mean ± SDb 
1   Al    31.5 ± 3.2def 
Pp    26.9 ± 3.7gh 
2   Al    36.0 ± 2.1b 
Pp    31.7 ± 4.1cdef 
3      Al    42.5 ± 6.6a 
Pp    33.9 ± 1.5bcde 
5   Al    34.1 ± 2.6bcde 
  Pp    28.7 ± 1.6fg 
6   Al    34.7 ± 3.9bcd 
  Pp    29.2 ± 5.3fg 
7     Al    35.3 ± 3.6bc 
  Pp    29.7 ± 2.5fg 
8     Al    36.1 ± 5.6b 
  Pp     30.5 ± 2.4efg 
9    Al    35.5 ± 4.7b 
  Pp    24.1 ± 5.4h 
10    Al    40.5 ± 5.3a 
  Pp    27.3 ± 2.5gh  
a Al=Alcalase; Pp= Pepsin pancreatin 
b Values mean ± standard deviation (SD), followed by the same letter(s) are not significantly 
different from each other (P > 0.05); n = 20 
 
 
 
Table J.2 Effect of location and processing on antioxidant capacity of alcalase and 
pepsin pancreatin hydrolysates (μM TE/μg soluble protein) 
 
Locationa  Processingb  Mean ± SDc 
F   Al   37.1 ± 4.0a 
  Pp   29.0 ± 4.0c 
H   Al   38.1 ± 5.3a 
  Pp   28.5 ± 5.8c 
B   Al   33.5 ± 5.4b 
  Pp   29.8 ± 2.5c 
a B=Bloomington; F=Findlay; H=Huxley 
b Al=Alcalase; Pp= Pepsin pancreatin 
c Values mean ± standard deviation (SD), followed by the same letter(s) are not significantly 
different from each other (P > 0.05); n = 6 
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Appendix K 
 
 
 
Figure K.1 Antioxidant capacity of soy protein hydrolysates of cultivar 3 across all 
locations.
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Appendix L 
 
Table L.1 Physical description of SAI beverages and ingredients.  
 
SAI Samples     Descriptiona 
1      Light brown solution, some settling at the bottom 
2      Creamy white solution, some settling at the bottom 
3      Dark brown solution, dark red precipitation, some settling at the bottom 
4      Dark brown solution, dark red precipitation, some settling at the bottom 
5      Colorless, dissolve completely 
6      Not soluble completely 
7      Slightly soluble 
8      Colorless, dissolve completely 
9      Colorless, dissolve completely, slight bubbles at the top 
10      Slightly cloudy, dissolve completely 
11      Cloudy, slight settling at the bottom 
12       Clear solution, lots of bubble and some settling at the bottom 
13      Light reddish clear solution 
14      Visible red precipitate, some settling at the bottom 
a Samples were dissolved in deionized water, except bolded samples which were dissolved in DMSO 
 
 
114 
 
Appendix M 
 
 
Commercial protein-based beverages purchased from a local pharmacy (Urbana, IL). 
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Appendix N 
 
 
 
 
Beverages and ingredients provided by SAI International (Geneva, IL). 
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Appendix O 
 
 
 
 
 
Figure O.1 Detection of α-amylase inhibitory activity was performed using starch as a 
substrate. Starch was hydrolyzed by α-amylase to reducing sugars such as maltose which 
would react with 3,5 dinitrosalicylic acid, causing reduction of 3,5 dinitrosalicylic acid to 
3-amino, 5 nitrosalicylic acid with concomitant change in absorbance that could be 
monitored at 540 nm.  
 
 
 
 
 
 
 
 
Figure O.2 Detection of α-glucosidase inhibitory activity was determined using p-
nitrophenyl-α-d-glucopyranoside (pNPG) as a substrate. The substrate was hydrolyzed by 
α-glucosidase to release p-nitrophenol, a color agent that could be monitored at 405 nm.  
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